Hillenbrand, Inc. - Quarter Report: 2020 June (Form 10-Q)

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ Quarterly Report Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

For the quarterly period ended June 30, 2020

☐ Transition Report Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

For the transition period from _____ to _____

Commission File Number. 001-33794

HILLENBRAND, INC.

(Exact name of registrant as specified in its charter)

Indiana

26-1342272

(State of incorporation)

(I.R.S. Employer Identification No.)

One Batesville Boulevard

Batesville

47006

(Address of principal executive offices)

(Zip Code)

(812) 934-7500

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, without par value

New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☒

Accelerated filer

☐

Emerging growth company

☐

Non-accelerated filer

☐

Smaller reporting company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The registrant had 74,731,178 shares of common stock, no par value per share, outstanding as of July 31, 2020.

Table of Contents

HILLENBRAND, INC.

INDEX TO FORM 10-Q


		Page
	PART I — FINANCIAL INFORMATION

Item 1.	Financial Statements (Unaudited)

	Consolidated Statements of Operations for the Three and Nine Months Ended June 30 , 2020 and 2019	2

	Consolidated Statements of Comprehensive Income (Loss) for the Three and Nine Months Ended June 30 , 2020 and 2019	3

	Consolidated Balance Sheets at June 30 , 2020 and September 30, 2019	4

	Consolidated Statements of Cash Flows for the Nine Months Ended June 30 , 2020 and 2019	5

	Consolidated Statements of Shareholders’ Equity for the Three and Nine Months Ended June 30 , 2020 and 2019	6

	Condensed Notes to Consolidated Financial Statements	8

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	34

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	55

Item 4.	Controls and Procedures	55

	PART II — OTHER INFORMATION

Item 1.	Legal Proceedings	56

Item 1A.	Risk Factors	56

Item 6.	Exhibits	61

SIGNATURES

Table of Contents

PART I — FINANCIAL INFORMATION

Item 1. FINANCIAL STATEMENTS

Hillenbrand, Inc.

Consolidated Statements of Operations (Unaudited)

(in millions, except per share data)


	Three Months Ended June 30,						Nine Months Ended June 30,
	2020		2019		2020		2019
Net revenue	$	607.5	$	446.6	$	1,823.3	$	1,321.5
Cost of goods sold	400.2		298.2		1,250.5		865.2
Gross profit	207.3		148.4		572.8		456.3
Operating expenses	118.5		90.8		411.9		275.2
Amortization expense	16.4		8.6		55.2		25.0
Impairment charges	—		—		82.5		—
Interest expense	19.7		5.2		55.3		16.1
Other income (expense), net	0.6		(0.5)		1.8		0.1
Income (loss) before income taxes	53.3		43.3		(30.3)		140.1
Income tax expense	28.3		11.6		17.7		39.9
Consolidated net income (loss)	25.0		31.7		(48.0)		100.2
Less: Net income attributable to noncontrolling interests	1.0		1.3		5.1		3.5
Net income (loss) attributable to Hillenbrand	$	24.0	$	30.4	$	(53.1)	$	96.7

Net income (loss) attributable to Hillenbrand — per share of common stock:
Basic earnings (loss) per share	$	0.32	$	0.48	$	(0.73)	$	1.54
Diluted earnings (loss) per share	$	0.32	$	0.48	$	(0.73)	$	1.52
Weighted average shares outstanding (basic)	75.1		63.0		72.8		62.9
Weighted average shares outstanding (diluted)	75.1		63.4		72.8		63.4

See Condensed Notes to Consolidated Financial Statements

Table of Contents

Hillenbrand, Inc.

Consolidated Statements of Comprehensive Income (Loss) (Unaudited)

(in millions)


	Three Months Ended June 30,						Nine Months Ended June 30,
	2020		2019		2020		2019
Consolidated net income (loss)	$	25.0	$	31.7	$	(48.0)	$	100.2
Changes in other comprehensive income (loss), net of tax:
Currency translation adjustment	11.9		6.1		(1.0)		(3.4)
Pension and postretirement (net of quarter-to-date tax of $0.4 and $0.5 and year-to-date tax of $1.3 and $0.7)	1.3		1.5		3.8		2.0
Change in net unrealized gain (loss) on derivative instruments (net of quarter-to-date tax of $0.3 and $1.2 and year-to-date tax of $0.3 and $3.8)	2.4		(4.3)		0.5		(12.7)

Total changes in other comprehensive income (loss), net of tax	15.6		3.3		3.3		(14.1)
Consolidated comprehensive income (loss)	40.6		35.0		(44.7)		86.1
Less: Comprehensive income attributable to noncontrolling interests	0.9		1.3		4.4		3.7
Comprehensive income (loss) attributable to Hillenbrand	$	39.7	$	33.7	$	(49.1)	$	82.4

See Condensed Notes to Consolidated Financial Statements

Table of Contents

Hillenbrand, Inc.

Consolidated Balance Sheets

(in millions)


	June 30, 2020 (unaudited)		September 30, 2019
ASSETS
Current Assets
Cash and cash equivalents	$	263.1	$	399.0
Trade receivables, net	297.2		217.4
Receivables from long-term manufacturing contracts	166.2		181.1
Inventories, net	424.3		176.6

Prepaid expenses and other current assets	93.7		49.1

Total current assets	1,244.5		1,023.2
Property, plant, and equipment, net	331.6		140.3
Operating lease right-of-use assets	161.4		—
Intangible assets, net	1,093.6		454.9
Goodwill	1,143.1		578.0
Other long-term assets	55.7		32.2
Total Assets	$	4,029.9	$	2,228.6

LIABILITIES
Current Liabilities
Trade accounts payable	$	264.9	$	236.2
Liabilities from long-term manufacturing contracts and advances	168.4		158.2
Current portion of long-term debt	36.3		—
Accrued compensation	87.8		73.2

Other current liabilities	211.6		121.7
Total current liabilities	769.0		589.3
Long-term debt	1,674.8		619.5
Accrued pension and postretirement healthcare	159.3		131.3
Operating lease liabilities	126.2		—
Deferred income taxes	187.6		73.6
Other long-term liabilities	57.9		45.1
Total Liabilities	2,974.8		1,458.8

Commitments and contingencies (Note 15)

SHAREHOLDERS’ EQUITY
Common stock, no par value (75.8 and 63.9 shares issued, 74.7 and 62.7 shares outstanding)	—		—
Additional paid-in capital	719.7		345.3
Retained earnings	504.4		599.5
Treasury stock (1.1 and 1.2 shares)	(44.9)		(50.1)
Accumulated other comprehensive loss	(142.6)		(140.6)
Hillenbrand Shareholders’ Equity	1,036.6		754.1
Noncontrolling interests	18.5		15.7
Total Shareholders’ Equity	1,055.1		769.8

Total Liabilities and Shareholders’ Equity	$	4,029.9	$	2,228.6

See Condensed Notes to Consolidated Financial Statements

Table of Contents

Hillenbrand, Inc.

Consolidated Statements of Cash Flows (Unaudited)

(in millions)


	Nine Months Ended June 30,
	2020		2019
Operating Activities
Consolidated net (loss) income	$	(48.0)	$	100.2
Adjustments to reconcile net (loss) income to cash provided by operating activities:
Depreciation and amortization	98.4		44.3
Impairment charges	82.5		—
Deferred income taxes	(23.4)		0.2
Amortization of deferred financing costs	2.5		0.9
Share-based compensation	9.4		8.7
Settlement of Milacron share-based equity awards	5.9		—
Net loss on divestiture	3.0		—
Trade accounts receivable and receivables from long-term manufacturing contracts	59.6		(15.5)
Inventories	35.9		(15.0)
Prepaid expenses and other current assets	6.5		(6.0)
Trade accounts payable	(76.4)		28.3
Liabilities from long-term manufacturing contracts and advances,
accrued compensation, and other current liabilities	(46.7)		(29.8)
Income taxes payable	15.5		(5.3)
Defined benefit plan and postretirement funding	(7.5)		(6.8)
Defined benefit plan and postretirement expense	4.6		2.6
Other, net	(1.7)		2.8
Net cash provided by operating activities	120.1		109.6

Investing Activities
Capital expenditures	(20.3)		(12.6)
Proceeds from sales of property, plant, and equipment	14.2		—

Acquisition of businesses, net of cash acquired	(1,503.1)		(25.9)
Proceeds from divestiture, net of cash divested	222.4		—
Other, net	—		0.1
Net cash used in investing activities	(1,286.8)		(38.4)

Financing Activities
Proceeds from issuance of long-term debt	1,125.2		—
Repayments on long-term debt	(27.2)		—
Proceeds from revolving credit facilities	1,157.8		449.7
Repayments on revolving credit facilities	(1,158.9)		(470.1)
Payment of deferred financing costs	(13.7)		—
Payments of dividends on common stock	(47.6)		(39.4)

Proceeds from stock option exercises	0.4		2.4
Payments for employee taxes on net settlement equity awards	(1.9)		(4.2)
Other, net	(3.0)		(0.9)
Net cash provided by (used in) financing activities	1,031.1		(62.5)

Effect of exchange rates on cash and cash equivalents	1.1		(0.2)

Net cash flows	(134.5)		8.5

Cash, cash equivalents, and restricted cash:
At beginning of period	399.4		56.5
At end of period	$	264.9	$	65.0

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Consolidated Balance Sheets that sum to the total of the same amounts shown in the Consolidated Statements of Cash Flows:


	June 30, 2020		June 30, 2019
Cash and cash equivalents	$	263.1	$	64.4
Short-term restricted cash included in other current assets	1.8		0.6
Total cash, cash equivalents, and restricted cash shown in the Consolidated Statements of Cash Flows	$	264.9	$	65.0

See Condensed Notes to Consolidated Financial Statements

Table of Contents

Hillenbrand, Inc.

Consolidated Statements of Shareholders’ Equity (Unaudited)

(in millions)


	Three Months Ended June 30, 2020
	Common Stock	Additional Paid-in Capital		Retained Earnings		Treasury Stock					Accumulated Other Comprehensive Loss		Noncontrolling Interests		Total
	Shares						Shares		Amount
Balance at March 31, 2020	75.8	$	716.3	$	496.4	1.1	$	(45.4)	$	(158.3)	$	18.0	$	1,027.0
Total other comprehensive income (loss), net of tax	—	—		—		—	—		15.7		(0.1)		15.6
Net income	—	—		24.0		—	—		—		1.0		25.0
Issuance/retirement of stock for stock awards/options	—	(0.4)		—		—	0.5		—		—		0.1
Share-based compensation	—	3.7		—		—	—		—		—		3.7
Dividends ($0.2125 per share)	—	0.1		(16.0)		—	—		—		(0.4)		(16.3)


Balance at June 30, 2020	75.8	$	719.7	$	504.4	1.1	$	(44.9)	$	(142.6)	$	18.5	$	1,055.1

	Nine Months Ended June 30, 2020
	Common Stock	Additional Paid-in Capital		Retained Earnings		Treasury Stock					Accumulated Other Comprehensive Loss		Noncontrolling Interests		Total
	Shares						Shares		Amount
Balance at September 30, 2019	63.9	$	345.3	$	599.5	1.2	$	(50.1)	$	(140.6)	$	15.7	$	769.8
Total other comprehensive income (loss), net of tax	—	—		—		—	—		4.0		(0.7)		3.3
Net (loss) income	—	—		(53.1)		—	—		—		5.1		(48.0)
Issuance/retirement of stock for stock awards/options	—	(6.7)		—		(0.1)	5.2		—		—		(1.5)
Share-based compensation	—	9.4		—		—	—		—		—		9.4
Dividends ($0.6375 per share)	—	0.4		(48.0)		—	—		—		(1.6)		(49.2)
Common stock issued to acquire Milacron (see Note 4)	11.9	371.3		—		—	—		—		—		371.3
Reclassification of certain income tax effects ⁽¹⁾	—	—		6.0		—	—		(6.0)		—		—
Balance at June 30, 2020	75.8	$	719.7	$	504.4	1.1	$	(44.9)	$	(142.6)	$	18.5	$	1,055.1

⁽¹⁾Income tax effects of the Tax Act (as defined in Note 2) were reclassified from accumulated other comprehensive loss to retained earnings due to the adoption of ASU 2018-02. See Note 2 for more information.

See Condensed Notes to Consolidated Financial Statements

Table of Contents

Hillenbrand, Inc.

Consolidated Statements of Shareholders’ Equity (Unaudited)

(in millions)


	Three Months Ended June 30, 2019
	Common Stock	Additional Paid-in Capital		Retained Earnings		Treasury Stock					Accumulated Other Comprehensive Loss		Noncontrolling Interests		Total
	Shares						Shares		Amount
Balance at March 31, 2019	63.9	$	343.1	$	571.1	1.3	$	(55.6)	$	(101.8)	$	13.3	$	770.1
Total other comprehensive income, net of tax	—	—		—		—	—		3.3		—		3.3
Net income	—	—		30.4		—	—		—		1.3		31.7
Issuance/retirement of stock for stock awards/options	—	(0.9)		—		—	1.9		—		—		1.0
Share-based compensation	—	2.9		—		—	—		—		—		2.9
Dividends ($0.2100 per share)	—	0.2		(13.4)		—	—		—		—		(13.2)


Balance at June 30, 2019	63.9	$	345.3	$	588.1	1.3	$	(53.7)	$	(98.5)	$	14.6	$	795.8

	Nine Months Ended June 30, 2019
	Common Stock	Additional Paid-in Capital		Retained Earnings		Treasury Stock					Accumulated Other Comprehensive Loss		Noncontrolling Interests		Total
	Shares						Shares		Amount
Balance at September 30, 2018	63.9	$	351.4	$	531.0	1.6	$	(67.1)	$	(84.2)	$	13.0	$	744.1
Total other comprehensive (loss) income, net of tax	—	—		—		—	—		(14.3)		0.2		(14.1)
Net income	—	—		96.7		—	—		—		3.5		100.2
Issuance/retirement of stock for stock awards/options	—	(15.2)		—		(0.3)	13.4		—		—		(1.8)
Share-based compensation	—	8.7		—		—	—		—		—		8.7
Dividends ($0.6300 per share)	—	0.4		(39.8)		—	—		—		(2.1)		(41.5)

Other	—	—		0.2		—	—		—		—		0.2
Balance at June 30, 2019	63.9	$	345.3	$	588.1	1.3	$	(53.7)	$	(98.5)	$	14.6	$	795.8

See Condensed Notes to Consolidated Financial Statements

Table of Contents

Hillenbrand, Inc.

Condensed Notes to Consolidated Financial Statements (Unaudited)

(in millions, except share and per share data)

1.Background and Basis of Presentation

Hillenbrand, Inc. (the “Company” or “Hillenbrand”) is a global diversified industrial company with multiple leading brands that serve a wide variety of industries around the world. The Company strives to provide superior return for our shareholders, exceptional value for our customers, great professional opportunities for our employees, and to be responsible to our communities through deployment of the Hillenbrand Operating Model (“HOM”). The HOM is a consistent and repeatable framework designed to produce sustainable and predictable results. The HOM describes the Company’s mission, vision, values, and mindset as leaders; applies our management practices in Strategy Management, Segmentation, Lean, Talent Development, and Acquisitions; and prescribes three steps (Understand, Focus, and Grow) designed to make the Company’s businesses both bigger and better. The Company’s goal is to continue developing Hillenbrand as a world-class global diversified industrial company through the deployment of the HOM.

On July 12, 2019, Hillenbrand entered into a definitive agreement (the “Merger Agreement”) to acquire Milacron Holdings Corp. (“Milacron”) in a cash and stock merger transaction. The Company completed the acquisition on November 21, 2019 through a merger of its wholly-owned subsidiary with and into Milacron, resulting in ownership of 100% of Milacron’s common stock that was issued and outstanding after the merger. The Consolidated Financial Statements include the financial results of Milacron from the date of acquisition. See Note 4 for further information on the acquisition.

Hillenbrand’s portfolio is composed of three reportable operating segments: the Process Equipment Group, Milacron^®, and Batesville^®. The Process Equipment Group businesses design, develop, manufacture, and service highly engineered industrial equipment around the world. Milacron is a global leader in highly engineered and customized systems in plastic technology and processing. Batesville is a recognized leader in the death care industry in North America. “Hillenbrand,” the “Company,” “we,” “us,” “our,” and similar words refer to Hillenbrand and its subsidiaries within this Form 10-Q unless context otherwise requires.

The accompanying unaudited Consolidated Financial Statements include the accounts of Hillenbrand and its subsidiaries. They also include two subsidiaries where the Company’s ownership percentage is less than 100%. The Company’s fiscal year ends on September 30. Unless otherwise stated, references to years relate to fiscal years.

These unaudited Consolidated Financial Statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial statements and therefore do not include all information required in accordance with United States generally accepted accounting principles (“GAAP”). The unaudited Consolidated Financial Statements have been prepared on the same basis as, and should be read in conjunction with, the audited Consolidated Financial Statements and notes thereto included in the Company’s latest Annual Report on Form 10-K for the year ended September 30, 2019, as filed with the SEC. In the opinion of management, these Consolidated Financial Statements reflect all adjustments necessary to present a fair statement of the Company’s consolidated financial position and the consolidated results of operations and cash flows as of the dates and for the periods presented. The interim period results are subject to variation and are not necessarily indicative of the results of operations to be expected for the full fiscal year.

The preparation of the Consolidated Financial Statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates. Examples of such estimates include, but are not limited to, revenue recognition under the percentage-of-completion method, preliminary purchase price allocations, determination of reporting unit and identifiable intangible asset fair value, and the establishment of reserves related to customer rebates, doubtful accounts, warranties, early-pay discounts, inventories, income taxes, litigation, self-insurance, and progress toward achievement of performance criteria under incentive compensation programs.

On March 11, 2020, the World Health Organization declared the outbreak of the novel strain of coronavirus (“COVID-19”) a global pandemic and recommended containment and mitigation measures worldwide, and the effects of the COVID-19 pandemic and such associated measures on management’s estimates and results of operations through June 30, 2020 are reflected in the Consolidated Financial Statements. Given the unprecedented nature of the COVID-19 pandemic, the Company cannot reasonably estimate the full extent of the impact that COVID-19 will have on its consolidated financial condition, results of operations, or cash flows in the foreseeable future. The ultimate impact of COVID-19 on the Company is highly uncertain and will depend on future developments, and such impacts could exist for an extended period of time, even after the COVID-19

Table of Contents

pandemic subsides. Events and changes in circumstances arising after June 30, 2020, including those resulting from the ongoing impacts of the COVID-19 pandemic, will be reflected in management’s estimates for future periods in subsequent periodic filings.

2.Summary of Significant Accounting Policies

The significant accounting policies used in preparing the Consolidated Financial Statements are consistent with the accounting policies described in the Company’s Annual Report on Form 10-K for 2019, except as described below.

Recently Adopted Accounting and Reporting Standards

In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-02, Leases (“ASU 2016-02”). ASU 2016-02 requires lessees to recognize a right of use asset and related lease liability for leases that have terms of more than twelve months. For income statement purposes, the FASB retained a dual model, requiring leases to be classified as either operating or finance, with the classifications based on criteria that are similar to those applied under the current lease guidance, without the explicit bright lines. ASU 2016-02 became effective for the Company’s fiscal year that began on October 1, 2019. The Company adopted ASU 2016-02 under the allowable transition method to use the effective date as the date of initial application on transition without adjusting the comparative periods presented (modified retrospective method).

At transition, the Company elected the package of practical expedients to not reassess prior conclusions related to contracts containing leases, lease classification, and initial direct costs. Additionally, ASU 2016-02 also provides practical expedients for an entity’s ongoing accounting. The Company elected to not separate lease and non-lease components. Additionally, the Company will not recognize an asset for leases with a term of twelve months or less and will apply a portfolio approach in determining discount rates.

The Company surveyed its businesses, assessed its portfolio of leases, and compiled a central repository of all leases. Additionally, the Company identified and implemented appropriate changes to policies, procedures, and controls pertaining to existing and future lease arrangements to support recognition and disclosure requirements under ASU 2016-02. As a result of the adoption of ASU 2016-02, the Company recorded right-of-use assets of $161.4 and corresponding lease liabilities of $158.9 for its operating leases at June 30, 2020. The adoption of ASU 2016-02 did not have a material impact to the Consolidated Statements of Operations or Consolidated Statements of Cash Flows. See Note 6 for additional information.

In February 2018, the FASB issued ASU 2018-02, Income Statement-Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (“ASU 2018-02”). ASU 2018-02 allows for the reclassification of stranded tax effects resulting from the Tax Cuts and Jobs Act of 2017 (the “Tax Act”) from accumulated other comprehensive loss to retained earnings. The Company adopted ASU 2018-02 on October 1, 2019, which resulted in a decrease to accumulated other comprehensive loss and an increase to retained earnings of $6.0 each on the Consolidated Balance Sheets, primarily related to deferred taxes previously recorded for pension and other postretirement benefits. The adoption of ASU 2018-02 did not have an impact to the Consolidated Statements of Operations or Consolidated Statements of Cash Flows.

In March 2020, the SEC amended Rule 3-10 of Regulation S-X regarding financial disclosure requirements for registered debt offerings involving subsidiaries as either issuers or guarantors and affiliates whose securities are pledged as collateral. This new guidance narrows the circumstances that require separate financial statements of subsidiary issuers and guarantors and streamlines the alternative disclosure required in lieu of those statements. We adopted these amendments as of and for the quarter ended June 30, 2020. Accordingly, combined summarized financial information has been presented only for the issuer and guarantors of our senior notes for the most recent fiscal year and the year-to-date interim period, and the location of the required disclosures has been removed from the Condensed Notes to the Consolidated Financial Statements and moved to Part I, Item 2, of Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Table of Contents

Recently Issued Accounting Standards

In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Statements (“ASU 2016-13”). ASU 2016-13 replaces the current incurred loss impairment model with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to determine credit loss estimates. ASU 2016-13 will be effective for the Company’s fiscal year beginning on October 1, 2020. The Company is currently evaluating the impact that ASU 2016-13 will have on the Consolidated Financial Statements and believes the primary impact of ASU 2016-13 will relate to the Company's assessment of its allowance for doubtful accounts on trade receivables and receivables from long-term manufacturing contracts. The Company does not expect the adoption of ASU 2016-13 to have a material impact on the Consolidated Financial Statements.

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-13”). ASU 2019-13 clarifies and simplifies accounting for income taxes by eliminating certain exceptions for intraperiod tax allocation principles, the methodology for calculating income tax rates in an interim period, and recognition of deferred taxes for outside basis differences in an investment, among other updates. ASU 2019-12 will be effective for the Company’s fiscal year beginning on October 1, 2021. The Company is currently evaluating the impact of ASU 2019-12 on the Consolidated Financial Statements.

No other new accounting pronouncements recently adopted or issued had or are expected to have a material impact on the Consolidated Financial Statements.

3.Revenue Recognition

Net revenue includes gross revenue less sales discounts, customer rebates, sales incentives, and product returns, all of which require the Company to make estimates for the portion of these allowances that have yet to be credited or paid to customers. The Company estimates these allowances using the expected value method, which is based upon historical rates and projections of customer purchases toward contractual rebate thresholds.

Contract balances

The balance of receivables from long-term manufacturing contracts at June 30, 2020 and September 30, 2019 was $166.2 and $181.1, respectively. The change was driven by the impact of net revenue recognized prior to billings. The balance of liabilities from long-term manufacturing contracts and advances at June 30, 2020 and September 30, 2019 was $168.4 and $158.2, respectively, and consists primarily of cash payments received in advance of satisfying performance obligations. The revenue recognized for the nine months ended June 30, 2020 and 2019 related to liabilities from long-term manufacturing contracts and advances as of September 30, 2019 and 2018 was $104.7 and $113.0, respectively. During the three and nine months ended June 30, 2020 and 2019, the adjustments related to performance obligations satisfied in previous periods were immaterial.

Transaction price allocated to the remaining performance obligations

As of June 30, 2020, the aggregate amount of transaction price of remaining performance obligations within the Process Equipment Group and Milacron reportable segments, which corresponds to backlog as defined in Item 2 of this Form 10-Q, was $1,123.7. Approximately 78% of these performance obligations are expected to be satisfied over the next twelve months, and the remaining performance obligations, primarily within one to three years.

Disaggregation of revenue

As a result of completing the acquisition of Milacron during the current fiscal year, the Company now sells products in the following additional end markets: custom molders, automotive, consumer goods, packaging, electronics, and construction. The following tables present net revenue by end market, which include reclassifications in the prior year period to conform to the current year presentation:

Table of Contents


	Three Months Ended June 30, 2020														Nine Months Ended June 30, 2020
	Process Equipment Group		Milacron		Batesville		Total		Process Equipment Group		Milacron		Batesville		Total
End Market
Plastics	$	181.0	$	—	$	—	$	181.0	$	589.6	$	—	$	—	$	589.6
Automotive	—		28.7		—		28.7		—		91.8		—		91.8
Chemicals	21.5		—		—		21.5		69.9		—		—		69.9
Consumer goods	—		25.4		—		25.4		—		76.6		—		76.6
Food and pharmaceuticals	19.7		—		—		19.7		54.9		—		—		54.9
Custom molders	—		28.4		—		28.4		—		66.5		—		66.5
Packaging	—		23.8		—		23.8		—		60.5		—		60.5
Construction	—		20.0		—		20.0		—		51.8		—		51.8
Minerals and mining	15.0		—		—		15.0		43.7		—		—		43.7
Electronics	—		20.3		—		20.3		—		43.1		—		43.1
Death care	—		—		139.9		139.9		—		—		405.7		405.7
Other industrial	44.1		39.7		—		83.8		140.9		128.3		—		269.2
Total	$	281.3	$	186.3	$	139.9	$	607.5	$	899.0	$	518.6	$	405.7	$	1,823.3


	Three Months Ended June 30, 2019								Nine Months Ended June 30, 2019
	Process Equipment Group		Batesville		Total		Process Equipment Group		Batesville		Total
End Market
Plastics	$	197.9	$	—	$	197.9	$	561.0	$	—	$	561.0
Chemicals	28.3		—		28.3		80.8		—		80.8
Food and pharmaceuticals	20.0		—		20.0		60.9		—		60.9
Minerals and mining	14.1		—		14.1		64.3		—		64.3
Death care	—		131.3		131.3		—		397.3		397.3
Other industrial	55.0		—		55.0		157.2		—		157.2
Total	$	315.3	$	131.3	$	446.6	$	924.2	$	397.3	$	1,321.5

The following tables present net revenue by products and services:


	Three Months Ended June 30, 2020														Nine Months Ended June 30, 2020
	Process Equipment Group		Milacron		Batesville		Total		Process Equipment Group		Milacron		Batesville		Total
Products and Services
Equipment	$	186.7	$	124.7	$	—	$	311.4	$	600.6	$	305.8	$	—	$	906.4
Parts and services	94.6		49.2		—		143.8		298.4		139.7		—		438.1
Death care	—		—		139.9		139.9		—		—		405.7		405.7
Other	—		12.4		—		12.4		—		73.1		—		73.1
Total	$	281.3	$	186.3	$	139.9	$	607.5	$	899.0	$	518.6	$	405.7	$	1,823.3

Table of Contents


	Three Months Ended June 30, 2019								Nine Months Ended June 30, 2019
	Process Equipment Group		Batesville		Total		Process Equipment Group		Batesville		Total
Products and Services
Equipment	$	212.4	$	—	$	212.4	$	623.4	$	—	$	623.4
Parts and services	102.9		—		102.9		300.8		—		300.8
Death care	—		131.3		131.3		—		397.3		397.3
Total	$	315.3	$	131.3	$	446.6	$	924.2	$	397.3	$	1,321.5

The following tables present net revenue by timing of transfer:


	Three Months Ended June 30, 2020														Nine Months Ended June 30, 2020
	Process Equipment Group		Milacron		Batesville		Total		Process Equipment Group		Milacron		Batesville		Total
Timing of Transfer
Point in time	$	151.6	$	186.3	$	139.9	$	477.8	$	448.3	$	518.6	$	405.7	$	1,372.6
Over time	129.7		—		—		129.7		450.7		—		—		450.7
Total	$	281.3	$	186.3	$	139.9	$	607.5	$	899.0	$	518.6	$	405.7	$	1,823.3


	Three Months Ended June 30, 2019								Nine Months Ended June 30, 2019
	Process Equipment Group		Batesville		Total		Process Equipment Group		Batesville		Total
Timing of Transfer
Point in time	$	164.6	$	131.3	$	295.9	$	505.1	$	397.3	$	902.4
Over time	150.7		—		150.7		419.1		—		419.1
Total	$	315.3	$	131.3	$	446.6	$	924.2	$	397.3	$	1,321.5

4.Business Acquisitions and Divestitures

Acquisition of Milacron

Background

On November 21, 2019, the Company completed the acquisition of Milacron, a global leader in highly engineered and customized systems in plastic technology and processing, through a merger of its wholly-owned subsidiary with and into Milacron, resulting in ownership of 100% of Milacron common stock that was issued and outstanding after the acquisition. The acquisition provides Hillenbrand with increased scale and meaningful product diversification, enhancing its ability to serve customers with expanded capabilities across the plastics value chain.

The results of Milacron are reported separately in its own reportable segment. See Note 17 for further information.

Purchase price consideration

As a result of the acquisition, Milacron stockholders received $11.80 in cash per share and a fixed exchange ratio of 0.1612 shares of Hillenbrand common stock for each share of Milacron common stock they owned, with cash paid in lieu of fractional shares. In addition, concurrent with the closing of the acquisition, the Company made a cash payment of $772.9 to repay outstanding Milacron debt, including accrued interest. The Company funded the acquisition through a combination of cash on hand, new debt financing, and the issuance of common stock. See Note 8 for a discussion of the debt financing.

Pursuant to the Merger Agreement, certain of Milacron’s outstanding stock options, restricted stock awards, restricted stock unit awards, and performance stock unit awards immediately vested and converted into the right to receive $11.80 per share in

Table of Contents

cash and 0.1612 shares of Hillenbrand common stock per share. Additionally, certain of Milacron’s stock appreciation rights were canceled and converted into the right to receive a lump sum cash payment. The fair value of share-based equity awards was apportioned between purchase price consideration and immediate expense. The portion of the fair value of partially vested awards associated with pre-acquisition service of Milacron employees represented a component of the total purchase price consideration, while the remaining portion of the fair value was immediately recognized as expense within operating expenses in the Consolidated Statement of Operations during the nine months ended June 30, 2020.

The following table summarizes the aggregate purchase price consideration to acquire Milacron:


Cash consideration paid to Milacron stockholders	$	835.9
Repayment of Milacron debt, including accrued interest	772.9
Cash consideration paid to settle outstanding share-based equity awards	34.2
Total cash consideration	1,643.0
Fair value of Hillenbrand common stock issued to Milacron stockholders ⁽¹⁾	356.9
Stock consideration issued to settle outstanding share-based equity awards ⁽¹⁾	14.4
Total consideration transferred	2,014.3
Portion of cash settlement of outstanding share-based equity awards recognized as expense ⁽²⁾	(14.1)
Portion of stock settlement of outstanding share-based equity awards recognized as expense ⁽²⁾	(5.9)
Total purchase price consideration	$	1,994.3

⁽¹⁾The fair value of the 11.4 million shares of Hillenbrand’s common stock issued as of the acquisition date was determined based on a per share price of $31.26, which was the closing price of Hillenbrand’s common stock on November 20, 2019, the last trading day before the acquisition closed on November 21, 2019. This includes a nominal amount of cash paid in lieu of fractional shares. Additionally, 0.5 million shares of Hillenbrand’s common stock were issued to settle certain of Milacron’s outstanding share-based equity awards, as previously discussed.

⁽²⁾In total, $20.0 was immediately recognized as expense within operating expenses in the Consolidated Statement of Operations during the nine months ended June 30, 2020, which represents the portion of the fair value of outstanding share-based equity awards that was not associated with pre-acquisition service of Milacron employees.

Purchase price allocation

The acquisition was accounted for as a business combination in accordance with Accounting Standards Codification (“ASC”) Topic 805, Business Combinations. The purchase price was allocated to the assets acquired and liabilities assumed based on management’s estimate of the respective fair values at the date of acquisition. Goodwill was calculated as the excess of the consideration transferred over the net assets recognized and represents the estimated future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. The factors contributing to the recognition of goodwill were based on strategic benefits that are expected to be realized from the acquisition. None of the goodwill is expected to be deductible for income tax purposes.

Table of Contents

The following table summarizes preliminary estimates of fair values of the assets acquired and liabilities assumed as of the acquisition date:


	November 21, 2019 (as initially reported)			Measurement Period Adjustments		November 21, 2019 (as adjusted)
Assets acquired:
Cash and cash equivalents	$	125.8		$	—	$	125.8
Trade receivables	135.5			1.3		136.8
Inventories	288.7			4.7		293.4
Prepaid expense and other current assets	64.3			1.3		65.6
Property, plant, and equipment	262.9			(22.7)		240.2
Operating lease right-of-use assets	41.3			—		41.3
Identifiable intangible assets	865.0			(50.0)		815.0
Goodwill	666.5			41.1		707.6
Other long-term assets	22.6			7.6		30.2
Total assets acquired	2,472.6		—	(16.7)		2,455.9

Liabilities assumed:
Trade accounts payable	110.2			—		110.2
Liabilities from long-term manufacturing contracts and advances	32.7			—		32.7
Accrued compensation	23.2			(2.4)		20.8
Other current liabilities	72.2			0.9		73.1
Accrued pension and postretirement healthcare	29.4			—		29.4
Deferred income taxes	166.3			(15.2)		151.1
Operating lease liabilities - long-term	31.2			—		31.2
Other long-term liabilities	13.1			—		13.1
Total liabilities assumed	478.3		—	(16.7)		461.6

Total purchase price consideration	$	1,994.3		$	—	$	1,994.3

Measurement period adjustments

The preliminary purchase price allocation was based upon a preliminary valuation, and the Company’s estimates and assumptions are subject to change within the measurement period (defined as one year following the acquisition date). As a result of further refining its estimates and assumptions since the date of the acquisition, the Company recorded measurement period adjustments to the initial opening balance sheet as shown in the table above. Adjustments were primarily made to property, plant, and equipment, identifiable intangible assets, goodwill, and deferred income taxes. There were no measurement period adjustments materially impacting earnings that would have been recorded in previous reporting periods if the adjustments had been recognized as of the acquisition date.

As of June 30, 2020, the allocation of the purchase price has not been finalized and the one-year measurement period has not ended. The primary areas of the preliminary purchase price allocation that are not yet finalized relate to the fair value of certain tangible assets acquired and liabilities assumed, the valuation of identifiable intangible assets acquired and deferred income taxes. The Company expects to continue to obtain information for the purpose of determining the fair value of the assets acquired and liabilities assumed at the acquisition date throughout the remainder of the measurement period.

Intangible assets identified

The preliminary purchase price allocation included $815.0 of acquired identifiable intangible assets. The preliminary fair value of the identifiable intangible assets has been estimated using the income approach through a discounted cash flow analysis. The cash flows are based on estimates used to price the Milacron acquisition, and the discount rates applied were benchmarked with reference to the implied rate of return to the Company’s pricing model and the weighted-average cost of capital. Definite-lived intangible assets are being amortized over the estimated useful life on a straight-line basis. The determination of the useful lives is based upon various industry studies, historical acquisition experience, economic factors, and future cash flows of the Company post-acquisition of Milacron. In addition, Hillenbrand reviewed certain technological trends and considered the relative stability in the current Milacron customer base.

Table of Contents

The preliminary amounts allocated to identifiable intangible assets are as follows:

Gross Carrying Amount

Weighted-Average Useful Life

Customer relationships

560.0

19 years

Trade names

150.0

Indefinite

Technology, including patents

95.0

10 years

Backlog

10.0

3 months

Total

815.0

The Company is required to provide additional disclosures about fair value measurements as part of the Consolidated Financial Statements for each major category of assets and liabilities measured at fair value on a nonrecurring basis (including business acquisitions). The working capital assets and liabilities, as well as the property, plant, and equipment acquired, were valued using Level 2 inputs which included data points that are observable, such as definitive sales agreements, appraisals or established market values of comparable assets (market approach). Goodwill and identifiable intangible assets were valued using Level 3 inputs, which are unobservable by nature, and included internal estimates of future cash flows (income approach). Significant increases (decreases) in any of those unobservable inputs in isolation would result in a significantly higher (lower) fair value measurement. Management used a third-party valuation firm to assist in the determination of the preliminary purchase accounting fair values, and specifically those considered Level 3 measurements along with Level 2 measurements for certain tangible assets. Management ultimately oversees the third-party valuation firm to ensure that the transaction-specific assumptions are appropriate for the Company.

Impact on results of operations

The results of Milacron’s operations have been included in the Consolidated Financial Statements since the November 21, 2019 acquisition date. The following table provides the results of operations for Milacron included in the Consolidated Statements of Operations for the three and nine months ended June 30, 2020:


	Three Months Ended June 30, 2020		Nine Months Ended June 30, 2020
Net revenue	$	186.3	$	518.6
Income (loss) before income taxes	12.0		(17.5)

In connection with the acquisition of Milacron, the Company incurred a total of $5.0 and $62.7 of business acquisition and integration costs during the three and nine months ended June 30, 2020, respectively, which were recorded within operating expenses in the Consolidated Statements of Operations.

Supplemental Pro Forma Information

The supplemental pro forma financial information presented below is for illustrative purposes only and is not necessarily indicative of the financial position or results of operations that would have been realized if the Milacron acquisition had been completed on the date indicated, does not reflect synergies that might have been achieved, nor is it indicative of future operating results or financial position. The pro forma adjustments are based upon currently available information and certain assumptions that Hillenbrand believes are reasonable under the circumstances.

The supplemental pro forma financial information reflects pro forma adjustments to present the combined pro forma results of operations as if the Milacron acquisition had occurred on October 1, 2018 to give effect to certain events that Hillenbrand believes to be directly attributable to the Milacron acquisition. These pro forma adjustments primarily include:

•an increase to depreciation and amortization expense that would have been recognized due to acquired tangible and identifiable intangible assets;

•an adjustment to interest expense to reflect the additional borrowings of Hillenbrand and the repayment of Milacron’s historical debt in conjunction with the acquisition;

•an adjustment to remove business acquisition and integration costs, inventory step-up costs, and backlog amortization during the three and nine months ended June 30, 2020, as these costs are non-recurring in nature and will not have a continuing effect on Hillenbrand’s results; and

Table of Contents

•the related income tax effects of the adjustments noted above.

The supplemental pro forma financial information for the periods presented is as follows:


	Three Months Ended June 30,						Nine Months Ended June 30,
	2020		2019		2020		2019
Net revenue	$	607.5	$	718.0	$	1,939.0	$	2,132.1
Net income (loss) attributable to Hillenbrand	30.4		23.0		(0.7)		85.1

Net income (loss) attributable to Hillenbrand — per share of common stock:
Basic earnings (loss) per share	$	0.40	$	0.31	$	(0.01)	$	1.14
Diluted earnings (loss) per share	$	0.40	$	0.31	$	(0.01)	$	1.13

Sale of Milacron facility

In December 2019, the Company completed the sale of a Milacron manufacturing facility located in Germany. As a result of the sale, the Company received net cash proceeds of $13.1 during the nine months ended June 30, 2020. There was no material impact to the Consolidated Statement of Operations resulting from the sale of the facility during the nine months ended June 30, 2020.

Divestiture of Cimcool

On March 30, 2020, the Company completed the sale of its Cimcool business (“Cimcool”), which represented the former Fluids Technologies reportable segment of Milacron before its acquisition by the Company, to DuBois Chemicals, Inc. The sale resulted in cash proceeds received at closing of $222.4, net of cash divested.

In addition, the Company may receive contingent consideration for the sale of Cimcool of up to an aggregate of $26.0 based on multiple earn-out provisions. The Company accounts for contingent consideration under a loss recovery approach. Under a loss recovery approach, the Company records a contingent consideration asset only to the extent of the lesser of (1) the amount that the non-contingent consideration received is exceeded by the net assets deconsolidated, or (2) the amount of contingent consideration that it is probable will be received. As of the transaction date (and at June 30, 2020), the Company was unable to determine that it was probable that any of the contingent consideration would be received, and accordingly no asset was recorded for contingent consideration. Subsequent measurement of contingent consideration will be based on the guidance for gain contingencies and any gain from contingent consideration will be recorded at the time the consideration is received.

As a result of the sale, the Company recorded a pre-tax loss of $3.0, using Level 2 nonrecurring fair value measurements, within other income (expense), net in the Consolidated Statement of Operations during the nine months ended June 30, 2020. The related tax effect resulted in tax expense of $13.0 and was included within income tax expense in the Consolidated Statement of Operations during the nine months ended June 30, 2020. The Company incurred $0.4 and $4.2 of transaction costs associated with the sale during the three and nine months ended June 30, 2020, respectively, which were recorded within operating expenses in the Consolidated Statements of Operations.

The Company determined that the sale of Cimcool did not represent a strategic shift that had or will have a major effect on its consolidated results of operations, and therefore Cimcool was not classified as a discontinued operation. Cimcool’s results of operations were included within the Milacron reportable segment until the completion of the sale on March 30, 2020.

Acquisition of Burnaby Machine and Mill Equipment Ltd.

The Company completed the acquisition of Burnaby Machine and Mill Equipment Ltd. (“BM&M”) in November 2018 for $25.9 in cash, which included post-closing working capital adjustments. The Company used its revolving credit facility to fund the acquisition. Based in Canada, BM&M provides high-speed gyratory screeners for a variety of industries. The results of BM&M are reported in the Process Equipment Group reportable segment.

Table of Contents

5.Supplemental Consolidated Balance Sheet Information


	June 30, 2020		September 30, 2019
Trade accounts receivable reserves	$	22.3	$	22.8

Accumulated depreciation on property, plant, and equipment	$	341.9	$	309.0

Inventories, net:
Finished goods	$	178.5	$	60.3
Raw materials and components	146.0		72.3
Work in process	99.8		44.0
Total inventories, net	$	424.3	$	176.6

Trade accounts receivable reserves consist of the allowance of doubtful accounts, which is a best estimate of the amount of probable credit losses and collection risk in the existing trade receivables portfolio, and the allowance for cash discounts and sales returns, which is based upon historical experience and trends. The Company considers a variety of factors when determining the accounts receivable reserves including macroeconomic conditions, specific industry trends, and customer classes. The Company specifically considered the impact of the COVID-19 pandemic on its trade receivables and inventories, and determined there was no material impact on existing trade receivables or inventories at June 30, 2020.

6.Leases

The Company’s lease portfolio is comprised of operating leases primarily for manufacturing facilities, offices, vehicles, and certain equipment. At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on whether the contract conveys the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration. Leases are classified as operating or finance leases at the commencement date of the lease. Operating leases are recorded within operating lease right-of-use assets, other current liabilities, and operating lease liabilities in the Consolidated Balance Sheets. The Company’s finance leases were insignificant as of June 30, 2020. Leases with an initial term of 12 months or less are not recorded on the Consolidated Balance Sheets. We have elected an accounting policy to combine lease and non-lease components for all leases.

Operating lease right-of-use assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As the implicit rate is generally not readily determinable for most leases, the Company uses an incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The incremental borrowing rate reflects the estimated rate of interest that the Company would pay to borrow on a collateralized basis over a similar term in a similar economic environment. Lease expense for operating leases is recognized on a straight-line basis over the lease term.

Leases may include renewal options, and the renewal option is included in the lease term if the Company concludes that it is reasonably certain that the option will be exercised. A certain number of the Company’s leases contain rent escalation clauses, either fixed or adjusted periodically for inflation of market rates, that are factored into the calculation of lease payments to the extent they are fixed and determinable at lease inception. The Company also has variable lease payments that do not depend on a rate or index, primarily for items such as common area maintenance and real estate taxes, which are recorded as variable costs when incurred.

For the three and nine months ended June 30, 2020, the Company recognized $9.2 and $27.0, respectively, of operating lease expense, including short-term lease expense and variable lease costs, which were immaterial in both periods.

Table of Contents

The following table presents supplemental Consolidated Balance Sheet information related to the Company’s operating leases:


	June 30, 2020
Operating lease right-of-use assets	$	161.4

Other current liabilities	32.7
Operating lease liabilities	126.2
Total operating lease liabilities	$	158.9

Weighted-average remaining lease term (in years)	7.6

Weighted-average discount rate	2.5		%

As of June 30, 2020, the maturities of the Company’s operating lease liabilities were as follows:


2020 (excluding the nine months ended June 30, 2020)	$	13.4
2021	33.7
2022	28.8
2023	23.0
2024	16.3
Thereafter	58.2
Total lease payments	173.4
Less: imputed interest	(14.5)
Total present value of lease payments	$	158.9

Supplemental Consolidated Statement of Cash Flow information is as follows:


	Nine Months Ended June 30, 2020
Cash paid for amounts included in the measurement of operating lease liabilities	$	28.0
Operating lease right-of-use assets obtained in exchange for new operating lease liabilities	22.1

7.Intangible Assets and Goodwill

Impairment assessment

Annual impairment assessment

Testing for impairment of goodwill and indefinite lived assets must be performed annually, or on an interim basis upon the occurrence of triggering events or substantive changes in circumstances that indicate that the fair value of the asset or reporting unit may have decreased below the carrying value. The Company’s annual assessment was performed in the third quarter of 2020 and consists of determining each reporting unit’s current fair value compared to its current carrying value. For all reporting units tested, the fair value of goodwill was determined to exceed the carrying value, resulting in no further impairment to goodwill. Additionally, the fair value of indefinite lived trade names was determined to meet or exceed the carrying value for all trade names, resulting in no further impairment to trade names.

Interim impairment assessment

In connection with the preparation of the Consolidated Financial Statements for the second quarter of 2020, an interim impairment assessment was performed for select reporting units within the Process Equipment Group and Milacron reportable segments as a result of certain triggering events and changes in circumstances discussed in detail below. Additionally, based on the macroeconomic factors below, as well as the decline in the Company’s common stock price during the second quarter of 2020, the Company performed a qualitative review for all remaining reporting units and determined that those reporting units did not require an interim impairment test as it was more likely than not that the current fair value of those reporting units exceeded their carrying value, based on their current and projected financial performance as well as the headroom from previous goodwill impairment tests.

Table of Contents

For certain reporting units within the Process Equipment Group reportable segment, an interim impairment review was triggered during the second quarter of 2020 by the Company’s decision to redirect its strategic investments as it remains focused on deleveraging following two major events: (1) the continued evaluation of the Company’s operations following the acquisition of Milacron completed on November 21, 2019, and (2) current adverse macroeconomic conditions primarily driven by the COVID-19 pandemic. In connection with these events, the Company made the decision to limit its future strategic investment in its two reporting units that primarily sell and manufacture products in the flow control sector. The decision to limit future investment, as well as the Company’s updated forecasts, which considered the impact of the COVID-19 pandemic, reduced those reporting units’ anticipated annual revenue growth rates and corresponding profitability and cash flows. The annual revenue growth rates utilized in the Company’s fair value estimate are consistent with the reporting units’ operating plans. As a result of the change to expected future cash flows, along with comparable fair value information, the Company concluded that the carrying value for these reporting units exceeded their fair value, resulting in goodwill impairment charges of $72.3 during the second quarter of 2020. The pre-impairment goodwill balance for these reporting units was $95.2. A 10% further reduction in the fair value of these reporting units would indicate a potential additional goodwill impairment of approximately $12.0. Additionally, under the relief-from-royalty fair value method, the Company concluded that the carrying value of a trade name associated with one of these reporting units exceeded its fair value. As a result, an impairment charge of $0.7 was recorded for this trade name during the second quarter of 2020. The pre-impairment balance for this trade name was $4.4. During the three months ended June 30, 2020, there were no material changes to the Company’s previous forecasts or significant changes in macroeconomic conditions that triggered an interim impairment review.

For the reporting units within the Milacron reportable segment, an interim impairment review was triggered during the second quarter of 2020, due to macroeconomic conditions primarily driven by the COVID-19 pandemic. Subsequent to the Company completing the acquisition of Milacron on November 21, 2019, the Company revised its forecasts for all reporting units within the Milacron reportable segment due to the deterioration in the overall global economy as a result of the pandemic. As a result of the decline in forecasted revenues, under the relief-from-royalty fair value method, the Company concluded that the carrying value of certain trade names and technology associated with these reporting units exceeded their fair value. As a result, impairment charges of $9.5 were recorded for these intangible assets during the second quarter of 2020. The pre-impairment balance for these intangible assets was $125.0. A 10% further reduction in the fair value of these intangible assets, caused by further declines in forecasted revenues and changes in the discount rate selected by the Company, would indicate a potential additional impairment of approximately $12.0. During the three months ended June 30, 2020, there were no material changes to the Company’s previous forecasts or significant changes in macroeconomic conditions that triggered an interim impairment review.

The impairment charges to goodwill and the identifiable intangible assets were nondeductible for tax purposes. The following table summarizes the impairment charges recorded by the Company during the nine months ended June 30, 2020:


	Impairment Charges
	Process Equipment Group		Milacron		Total
Goodwill	$	72.3	$	—	$	72.3
Trade names	0.7		7.9		8.6
Technology, including patents	—		1.6		1.6
Total	$	73.0	$	9.5	$	82.5

As a result of the interim impairment review triggered during the second quarter of 2020 for all reporting units within the Milacron reportable segment, as discussed above, the Company determined that no impairment of goodwill occurred for these reporting units. The estimated fair value, as calculated, for all four reporting units within the Milacron reportable segment ranged from approximately 3% to 16% greater than their carrying value. During the three months ended June 30, 2020, there were no material changes to the Company’s previous forecasts or significant changes in macroeconomic conditions that triggered an interim impairment review.

The valuation used to test goodwill for impairment is dependent upon a number of significant estimates and assumptions, including macroeconomic conditions, growth rates, competitive activities, cost containment, achievement of synergy initiatives, margin expansion, and the Company's business plans. The Company believes these estimates and assumptions are reasonable. However, future changes in the judgments, assumptions and estimates that are used in the impairment testing for goodwill, including discount and tax rates or future cash flow projections, could result in significantly different estimates of the fair values. As a result of these factors and the limited cushion (or headroom as commonly referred) due to the recent acquisition of Milacron, goodwill for the reporting units within the Milacron reportable segment are more susceptible to impairment risk.

Table of Contents

The most significant assumptions used in the determination of the estimated fair value of the reporting units are the revenue and EBITDA growth rates (including terminal growth rates) and the discount rate. The terminal growth rate represents the rate at which the reporting unit is expected to grow beyond the shorter-term business planning period. The terminal growth rate utilized in the Company’s fair value estimate is consistent with the reporting unit operating plans and approximates expected long-term category market growth rates and inflation. The discount rate, which is consistent with a weighted-average cost of capital that is likely to be expected by a market participant, is based upon industry required rates of return, including consideration of both debt and equity components of the capital structure. The discount rates may be impacted by adverse changes in the macroeconomic environment, specifically the COVID-19 pandemic, volatility in the equity and debt markets or other factors.

While the Company can implement and has implemented certain strategies to address these events, changes in operating plans or adverse changes in the future could reduce the underlying cash flows used to estimate reporting unit fair values and could result in a further decline in fair value that would trigger a future material impairment charge of the reporting units’ goodwill balance.

Intangible Assets

Intangible assets are stated at the lower of cost or fair value. With the exception of most trade names, intangible assets are amortized on a straight-line basis over periods ranging from three to 21 years, representing the period over which the Company expects to receive future economic benefits from these assets. The Company assesses the carrying value of most trade names annually, or more often if events or changes in circumstances indicate there may be an impairment.

The following table summarizes the carrying amounts and related accumulated amortization for intangible assets as of June 30, 2020 and September 30, 2019:


	June 30, 2020						September 30, 2019
	Cost		Accumulated Amortization		Cost		Accumulated Amortization
Finite-lived assets:
Trade names	$	0.2	$	(0.2)	$	0.2	$	(0.2)
Customer relationships	948.3		(206.0)		464.2		(169.2)
Technology, including patents	157.0		(59.1)		76.8		(49.4)
Software	70.8		(56.2)		58.7		(51.7)
Backlog	10.0		(10.0)		—		—
Other	0.1		(0.1)		0.2		(0.2)
	1,186.4		(331.6)		600.1		(270.7)
Indefinite-lived assets:
Trade names	238.8		—		125.5		—

Total	$	1,425.2	$	(331.6)	$	725.6	$	(270.7)

The net change in intangible assets during the nine months ended June 30, 2020 was driven primarily by the following:

•the acquisition of Milacron, which included acquired intangible assets of $815.0;

•the divestiture of Cimcool, which included divested gross intangible assets of $122.1;

•impairment charges to intangible assets of $10.2;

•normal amortization; and

•foreign currency adjustments.

Table of Contents

See Note 4 for further information on the acquisition of Milacron and the divestiture of Cimcool. Estimated amortization expense related to intangible assets for the next five years is as follows: $71.6 in 2020 (includes nine months actual and three months estimated), $65.8 in 2021, $64.8 in 2022, $64.3 in 2023, and $64.2 in 2024.

Goodwill

As discussed above, goodwill is not amortized but is tested for impairment at least annually, or on an interim basis upon the occurrence of triggering events or substantive changes in circumstances. Goodwill has been assigned to reporting units. The Company assesses the carrying value of goodwill annually, or more often if events or changes in circumstances indicate there may be impairment. Impairment testing is performed at a reporting unit level.

The following table summarizes the changes in the Company’s goodwill, by reportable segment, for the nine months ended June 30, 2020:


	Process Equipment Group		Milacron		Batesville		Total
Balance as of September 30, 2019	$	569.7	$	—	$	8.3	$	578.0
Acquisitions ⁽¹⁾	1.7		707.6		—		709.3
Divestiture ⁽²⁾	—		(77.9)		—		(77.9)
Impairment charges	(72.3)		—		—		(72.3)
Foreign currency adjustments	11.2		(5.2)		—		6.0
Balance as of June 30, 2020 ⁽³⁾	$	510.3	$	624.5	$	8.3	$	1,143.1

⁽¹⁾See Note 4 for further information on the acquisitions of Milacron and BM&M.

⁽²⁾See Note 4 for further information on the divestiture of Cimcool.

⁽³⁾There was accumulated goodwill impairment of $131.1 and $58.8 within the Process Equipment Group as of June 30, 2020 and September 30, 2019, respectively.

8.Financing Agreements

The following table summarizes Hillenbrand’s current and long-term debt as of the dates reported in the Consolidated Balance Sheets:


	June 30, 2020		September 30, 2019
$500.0 term loan ⁽¹⁾	$	479.9	$	—
$400.0 senior unsecured notes ⁽²⁾	394.5		—
$375.0 senior unsecured notes, net of discount ⁽³⁾	370.6		370.1
$225.0 term loan ⁽⁴⁾	216.2		—
$150.0 senior unsecured notes, net of discount ⁽⁵⁾	150.0		149.7
$100.0 Series A Notes ⁽⁶⁾	99.7		99.7
$900.0 revolving credit facility (excluding outstanding letters of credit)	—		—
Other	0.2		—
Total debt	1,711.1		619.5
Less: current portion	36.3		—
Total long-term debt	$	1,674.8	$	619.5

⁽¹⁾Includes unamortized debt issuance costs of $1.4 at June 30, 2020.

⁽²⁾Includes unamortized debt issuance costs of $5.5 at June 30, 2020.

⁽³⁾Includes unamortized debt issuance costs of $3.9 and $4.3 at June 30, 2020 and September 30, 2019, respectively.

⁽⁴⁾Includes unamortized debt issuance costs of $0.4 at June 30, 2020.

⁽⁵⁾Includes unamortized debt issuance costs of $0.2 at September 30, 2019.

⁽⁶⁾Includes unamortized debt issuance costs of $0.3 at both June 30, 2020 and September 30, 2019.

Table of Contents

The following table summarizes the scheduled maturities of long-term debt for 2020 through 2024:


	Amount
2020 (remaining three months) ⁽¹⁾	$	159.1
2021	36.3
2022	54.4
2023	223.1
2024	50.0

(1)Includes the $150.0 senior unsecured notes which matured in July 2020. Upon maturity, the Company refinanced the notes on a long-term basis, as they were repaid with available borrowing capacity from the Revolver. There were no outstanding borrowings under the Revolver as of June 30, 2020, primarily due to repayments made with proceeds from the $400.0 senior unsecured notes issued in June 2020. As such, these obligations were classified as long-term debt within the Consolidated Balance Sheet as of June 30, 2020.

$400.0 senior unsecured notes

On June 16, 2020, the Company issued $400.0 of senior unsecured notes due June 2025 (the “2020 Notes”). The 2020 Notes were issued at par value and bear interest at a fixed rate of 5.75% per year, payable semi-annually in arrears beginning December 2020. Deferred financing costs associated with the 2020 Notes of $5.5 are being amortized to interest expense on a straight-line basis over the term of the 2020 Notes. The 2020 Notes are unsubordinated obligations of the Company and rank equally in right of payment with all other existing and future unsubordinated obligations.

Subject to certain limitations, in the event of a change of control repurchase event, the Company will be required to make an offer to purchase the 2020 Notes at a price equal to 101% of the principal amount of the 2020 Notes, plus any accrued and unpaid interest to, but excluding, the date of repurchase. In addition, the 2020 Notes are redeemable with prior notice at a price equal to par plus accrued interest and a make-whole amount.

Financing for Milacron Acquisition

Upon completing the acquisition of Milacron on November 21, 2019, Hillenbrand incurred borrowings under its two term loans in aggregate principal amounts of $500.0 and $225.0 (the “Term Loan Facilities”), which are provided for under the Company’s Third Amended and Restated Credit Agreement dated August 28, 2019, as amended (the “Credit Agreement”). The $500.0 term loan matures on the fifth anniversary of the date on which it was borrowed, subject to quarterly amortization payments (equal to 5% of the original principal amount of the term loan in each of years 1 and 2, 7.5% in each of years 3 and 4, and 10% in year 5) and the $225.0 term loan matures on the third anniversary of the date on which it was borrowed, subject to quarterly amortization payments (equal to 5% of the original principal amount of the term loan in each of years 1 and 2, and 7.5% in year 3). The $500.0 term loan accrues interest, at the Company’s option, at the LIBO Rate or the Alternate Base Rate (each as defined in the Credit Agreement) plus a margin based on the Company’s leverage ratio, ranging from 1.00% to 2.375% for term loans bearing interest at the LIBO Rate and 0.0% to 1.375% for term loans bearing interest at the Alternate Base Rate. The $225.0 term loan accrues interest, at the Company’s option, at the LIBO Rate or the Alternate Base Rate plus a margin based on the Company’s leverage ratio, ranging from 0.875% to 2.25% for term loans bearing interest at the LIBO Rate and 0.0% to 1.25% for term loans bearing interest at the Alternate Base Rate. For the three and nine months ended June 30, 2020, the weighted average interest rates were 2.59% and 3.07%, respectively, for the $500.0 term loan and 2.46% and 2.94%, respectively, for the $225.0 term loan. Deferred financing costs of $2.0 are being amortized to interest expense over the respective terms of the Term Loan Facilities.

In addition to the Term Loan Facilities, Hillenbrand incurred $650.0 of additional borrowings from its revolving credit facility under the Credit Agreement (the “Revolver”) at the closing of the Milacron acquisition. The additional borrowings under the Term Loan Facilities and the Revolver, in addition to the $375.0 of senior unsecured notes issued during the quarter ended September 30, 2019, were used to pay a portion of the cash consideration in connection with the acquisition of Milacron, fees and expenses related to the acquisition, and to repay certain indebtedness of Milacron and its subsidiaries upon closing the acquisition.

With respect to the Revolver, the Company has made net repayments since the closing date of the acquisition of Milacron, resulting in no outstanding balance as of June 30, 2020. As of June 30, 2020, the Company had $8.1 in outstanding letters of credit issued and $891.9 of maximum borrowing capacity under the Revolver. $642.4 of this borrowing capacity was immediately available based on the Company’s most restrictive covenant at June 30, 2020. The weighted-average interest rates

Table of Contents

on borrowings under the Revolver were 2.59% and 2.78% for the three and nine months ended June 30, 2020, respectively, and 2.89% and 2.66% for the same periods in the prior year, respectively. The weighted average facility fee was 0.30% and 0.24% for the three and nine months ended June 30, 2020, respectively, and 0.13% and 0.12% for the same periods in the prior year, respectively.

Other credit arrangements

In the normal course of business, operating companies within the Process Equipment Group and Milacron reportable segments provide to certain customers bank guarantees and other credit arrangements in support of performance, warranty, advance payment, and other contractual obligations. This form of trade finance is customary in the industry and, as a result, the Company maintains adequate capacity to provide the guarantees. As of June 30, 2020, the Company had credit arrangements totaling $383.7, under which $267.4 was used for guarantees. These arrangements include the Company’s Syndicated Letter of Guarantee Facility (as amended, the “L/G Facility Agreement”) and other ancillary credit facilities. On January 10, 2020, the L/G Facility Agreement was amended to expand the size of the existing €150.0 facility by an additional €25.0.

Credit ratings update

The coupon rate on the Company’s $375.0 senior unsecured notes is impacted by public bond ratings from Moody’s and S&P Global. Downgrades from either rating agency will increase the coupon rate by 0.25% per downgrade level if the ratings are below investment grade. During the three months ended June 30, 2020, Moody’s and S&P Global each downgraded the Company’s senior unsecured credit rating by one level. As such, the original coupon rate of 4.5% on the $375.0 senior unsecured notes will increase to 5.0%, effective September 15, 2020.

Amendments to current financing agreements

On January 10, 2020, the Company amended the Credit Agreement, the L/G Facility Agreement, and the Private Shelf Agreement governing the Series A Notes, dated as of December 6, 2012 (as amended, the “Shelf Agreement”) to, among other things, (i) increase the maximum permitted leverage ratio and (ii) add additional pricing levels to compensate for the increase in permitted leverage ratios.

On May 19, 2020, the Company further amended the Credit Agreement, the L/G Facility Agreement, and the Shelf Agreement to, among other things, (i) increase the maximum permitted leverage ratio to (A) 4.75 to 1.00 for the quarters ending June 30, 2020, September 30, 2020, December 31, 2020, and March 31, 2021, (B) 4.25 to 1.00 for the quarter ending June 30, 2021, (C) 4.00 to 1.00 for the quarter ending September 30, 2021, (D) 3.75 to 1.00 for the quarter ending December 31, 2021, and (E) 3.50 to 1.00 for the quarter ending March 31, 2022 and each quarter ending thereafter; (ii) increase the margin paid on various rates defined in the Credit Agreement at certain pricing levels; (iii) add additional pricing levels to compensate for the increase in permitted leverage ratios; (iv) increase the interest rate floor for various rates defined in the Credit Agreement; (v) add as a condition to each borrowing under the Revolver that the amount of cash or cash equivalents on the Consolidated Balance Sheet not exceed $350.0, subject to certain exceptions; and (vi) impose certain restrictions on the Company’s ability to make restricted payments, including limitations on share repurchases and the payment of dividends, and grant liens on the Company’s assets until January 1, 2022.

With respect to these amendments, the Company incurred deferred financing costs of $3.6 during the nine months ended June 30, 2020, which are being amortized to interest expense over the applicable terms of the various amendments.

Covenants related to current financing agreements

The Credit Agreement, the L/G Facility Agreement, and the Shelf Agreement contain the following financial covenants for the current quarter: a maximum leverage ratio (as described above and defined in the agreements) of 4.75 to 1.00 and a minimum ratio of EBITDA (as defined in the agreements) to interest expense of 3.00 to 1.00.

As of June 30, 2020, Hillenbrand was in compliance with all covenants under these agreements. Additionally, the Credit Agreement, the L/G Facility Agreement, and the Shelf Agreement provide the Company with the ability to sell assets and to incur debt at its international subsidiaries under certain conditions.

All obligations of the Company arising under the Credit Agreement, the $400.0, $375.0, and $150.0 senior unsecured notes, the Series A Notes, and the L/G Facility Agreement are fully and unconditionally, and jointly and severally, guaranteed by certain of the Company’s domestic subsidiaries.

Table of Contents

The Credit Agreement, the L/G Facility Agreement, and the Shelf Agreement each contain certain other customary covenants, representations and warranties and events of default. The indentures governing the $400.0, $375.0 and $150.0 senior unsecured notes do not limit the Company’s ability to incur additional indebtedness. They do, however, contain certain covenants that restrict the Company’s ability to incur secured debt and to engage in certain sale and leaseback transactions. The indentures also contain customary events of default. The indentures provide holders of the senior unsecured notes with remedies if the Company fails to perform specific obligations. As of June 30, 2020, Hillenbrand was in compliance with all covenants and there were no events of default.

9.Retirement Benefits

Defined Benefit Plans

In connection with the Milacron acquisition, the Company acquired three noncontributory defined benefit plans for certain non-U.S. employees and retirees. One plan covers certain employees in the United Kingdom and the other two plans cover certain employees in Germany. The aggregate fair value of the liability assumed for these defined benefit plans was $30.7 at November 21, 2019. Contributions to these plans are expected to approximate benefit payments each year.

Components of net periodic pension cost included in the Consolidated Statements of Operations were as follows:


	U.S. Pension Benefits						Non-U.S. Pension Benefits
	Three Months Ended June 30,						Three Months Ended June 30,
	2020		2019		2020		2019
Service costs	$	0.4	$	0.5	$	0.7	$	0.4
Interest costs	2.0		2.4		0.2		0.3
Expected return on plan assets	(3.3)		(3.3)		(0.3)		(0.1)

Amortization of net loss	1.2		0.4		0.5		0.3
Net periodic pension cost	$	0.3	$	—	$	1.1	$	0.9

	U.S. Pension Benefits						Non-U.S. Pension Benefits
	Nine Months Ended June 30,						Nine Months Ended June 30,
	2020		2019		2020		2019
Service costs	$	1.1	$	1.7	$	1.8	$	1.1
Interest costs	6.0		7.5		0.5		0.9
Expected return on plan assets	(9.7)		(9.9)		(0.6)		(0.4)
Amortization of unrecognized prior service costs, net	—		0.1		—		—
Amortization of net loss	3.6		0.8		1.8		0.8
Net periodic pension cost	$	1.0	$	0.2	$	3.5	$	2.4

Defined Contribution Plans

In connection with the Milacron acquisition, the Company assumed a defined contribution plan (the “401(k) Plan”) for eligible U.S. employees and defined contribution plans for eligible employees at certain foreign subsidiaries. For the 401(k) Plan, eligible employees are permitted to contribute a percentage of their compensation and employees are immediately vested in their voluntary contributions. The Company’s contributions to the 401(k) Plan are based on matching a portion of the employee contributions and employees become vested in the Company contributions once they attain a year of credited service. For the assumed foreign plans, employees are immediately vested in both their voluntary and Company matching contributions.

Expenses related to the Company’s defined contribution plans were $3.7 and $10.8 for the three and nine months ended June 30, 2020, respectively, and $3.0 and $8.7 for the same periods in the prior year, respectively.

Table of Contents

10.Income Taxes

The effective tax rates for the three months ended June 30, 2020 and 2019 were 53.1% and 26.8%, respectively. The effective tax rate in the current quarter and the difference from the prior year is primarily due to the impact of Milacron carryforward tax attributes adversely impacting domestic taxes associated with the Tax Act, unfavorable geographic mix of income, and nondeductible acquisition expenses related to the Milacron acquisition.

The effective tax rates for the nine months ended June 30, 2020 and 2019 were (58.4)% and 28.5%, respectively. Due to the current year net loss position, the effective tax rate decreased over the prior year primarily as a result of the discrete recognition of tax expense on the divestiture of Cimcool, the impact of Milacron carryforward tax attributes adversely impacting domestic taxes associated with the Tax Act, unfavorable geographic mix of income, and nondeductible acquisition expenses related to the Milacron acquisition, net of the tax benefit recognized in 2020 from the revaluation of current and deferred tax balances in connection with the enacted statutory tax rate reductions in certain foreign jurisdictions. The change in the effective tax rate compared to the prior year was also impacted by the prior year increase in the reserve for unrecognized tax benefits that did not recur in the current year.

The acquisition of Milacron was completed as a taxable acquisition of the outstanding common stock of Milacron. In connection with the acquisition, the Company recorded a net deferred tax liability of $138.0 associated with the difference between the financial accounting basis and the tax basis in the acquired assets and liabilities assumed. Included in the acquired deferred taxes were deferred tax assets for the carryforward of Milacron’s tax net operating losses from federal, state, and foreign tax jurisdictions of $65.1, which were partially offset by the recognition of preliminary valuation allowances of $25.6 related to the estimated realizability of these items. The utilization of the acquired U.S. federal and state net operating losses to reduce Hillenbrand’s taxable income will be limited annually under Section 382 of the Internal Revenue Code. The Section 382 limitation analysis is in process as part of purchase accounting finalization and was not completed as of June 30, 2020. Additionally, Hillenbrand incurred transaction costs of $43.3 during the nine months ended June 30, 2020 associated with the acquisition of Milacron. A preliminary estimate of the nondeductible portion of these costs has been determined to be approximately $20.3 and recognized as an adjustment to the forecasted tax rate for the year. As the Company continues to analyze the tax attributes of the acquisition, it will revise these preliminary estimates and appropriately record the impact of any changes in estimates.

On July 20, 2020, the US Treasury and the Internal Revenue Service issued Final Regulations under Internal Revenue Code Section 951A relating to the treatment of income that is subject to a high rate of tax under the GILTI regime. Additionally, on July 28, 2020, the IRS issued Final and Proposed Regulations under Internal Revenue Code Section 163(j) relating to the business interest expense limitation. The Company is in the process of reviewing and estimating the impact of these regulations and the potential impact on the Consolidated Financial Statements, if any, will be recorded in subsequent periods.

11.Earnings per share

The dilutive effects of performance-based stock awards were included in the computation of diluted earnings per share at the level the related performance criteria were met through the respective balance sheet date. Potential dilutive effects, representing approximately 400,000 shares at both June 30, 2020 and 2019, were excluded from the computation of diluted earnings per share as the related performance criteria were not yet met, although the Company expects to meet various levels of criteria in the future.

Table of Contents


	Three Months Ended June 30,						Nine Months Ended June 30,
	2020		2019		2020		2019
Net income (loss) attributable to Hillenbrand	$	24.0	$	30.4	$	(53.1)	$	96.7
Weighted-average shares outstanding (basic - in millions) ⁽¹⁾	75.1		63.0		72.8		62.9
Effect of dilutive stock options and other unvested equity awards (in millions) ⁽²⁾	—		0.4		—		0.5
Weighted-average shares outstanding (diluted - in millions)	75.1		63.4		72.8		63.4

Basic earnings (loss) per share	$	0.32	$	0.48	$	(0.73)	$	1.54
Diluted earnings (loss) per share	$	0.32	$	0.48	$	(0.73)	$	1.52

Shares with anti-dilutive effect excluded from the computation of diluted earnings per share (in millions)	2.8		1.1		2.9		0.9

⁽¹⁾The increase in weighted-average shares outstanding during the nine months ended June 30, 2020 was due to 11.9 million of additional shares issued on November 21, 2019 in connection with the acquisition of Milacron. See Note 4 for further information.

⁽²⁾As a result of the net loss attributable to Hillenbrand during the nine months ended June 30, 2020, the effect of stock options and other unvested equity awards would be antidilutive. In accordance with GAAP, they have been excluded from the diluted earnings per share calculation.

12. Accumulated Other Comprehensive Loss

The following tables summarize the changes in the accumulated balances for each component of accumulated other comprehensive loss:


	Pension and Postretirement		Currency Translation		Net Unrealized Gain (Loss) on Derivative Instruments		Total Attributable to Hillenbrand, Inc.		Noncontrolling Interests		Total
Balance at September 30, 2019	$	(62.3)	$	(64.7)	$	(13.6)	$	(140.6)
Other comprehensive loss before reclassifications:
Before tax amount	—		(0.3)		(1.6)		(1.9)		$	(0.7)	$	(2.6)
Tax benefit	—		—		0.3		0.3		—		0.3
After tax amount	—		(0.3)		(1.3)		(1.6)		(0.7)		(2.3)
Amounts reclassified from accumulated other comprehensive loss ⁽¹⁾	3.8		—		1.8		5.6		—		5.6
Net current period other comprehensive income (loss)	3.8		(0.3)		0.5		4.0		$	(0.7)	$	3.3
Reclassification of certain income tax effects ⁽²⁾	(6.0)		—		—		(6.0)
Balance at June 30, 2020	$	(64.5)	$	(65.0)	$	(13.1)	$	(142.6)

⁽¹⁾Amounts are net of tax.

⁽²⁾Income tax effects of the Tax Act were reclassified from accumulated other comprehensive loss to retained earnings due to the adoption of ASU 2018-02. See Note 2 for more information.

Table of Contents


	Pension and Postretirement		Currency Translation		Net Unrealized Gain (Loss) on Derivative Instruments		Total Attributable to Hillenbrand, Inc.		Noncontrolling Interests		Total
Balance at September 30, 2018	$	(41.0)	$	(44.1)	$	0.9	$	(84.2)
Other comprehensive income (loss) before reclassifications:
Before tax amount	1.5		(3.6)		(16.2)		(18.3)		$	0.2	$	(18.1)
Tax (expense) benefit	(0.4)		—		3.8		3.4		—		3.4
After tax amount	1.1		(3.6)		(12.4)		(14.9)		0.2		(14.7)
Amounts reclassified from accumulated other comprehensive loss ⁽¹⁾	0.9		—		(0.3)		0.6		—		0.6
Net current period other comprehensive income (loss)	2.0		(3.6)		(12.7)		(14.3)		$	0.2	$	(14.1)
Balance at June 30, 2019	$	(39.0)	$	(47.7)	$	(11.8)	$	(98.5)

⁽¹⁾Amounts are net of tax.

Reclassifications out of accumulated other comprehensive loss include:


	Three Months Ended June 30, 2020
	Amortization of Pension and Postretirement ⁽¹⁾						(Gain) Loss on
	Net Loss Recognized		Prior Service Costs Recognized		Derivative Instruments		Total
Affected Line in the Consolidated Statement of Operations:
Net revenue	$	—	$	—	$	—	$	—
Cost of goods sold	—		—		0.9		0.9

Other income (expense), net	1.7		—		0.5		2.2
Total before tax	$	1.7	$	—	$	1.4	$	3.1
Tax benefit							(0.5)
Total reclassifications for the period, net of tax							$	2.6

	Nine Months Ended June 30, 2020
	Amortization of Pension and Postretirement ⁽¹⁾						(Gain) Loss on
	Net Loss Recognized		Prior Service Costs Recognized		Derivative Instruments		Total
Affected Line in the Consolidated Statement of Operations:
Net revenue	$	—	$	—	$	(0.2)	$	(0.2)
Cost of goods sold	—		—		0.5		0.5

Other income (expense), net	5.2		(0.1)		1.5		6.6
Total before tax	$	5.2	$	(0.1)	$	1.8	$	6.9
Tax benefit							(1.3)
Total reclassifications for the period, net of tax							$	5.6

⁽¹⁾These accumulated other comprehensive loss components are included in the computation of net periodic pension cost (see Note 9).

Table of Contents


	Three Months Ended June 30, 2019
	Amortization of Pension and Postretirement ⁽¹⁾						Gain (Loss) on
	Net Loss Recognized		Prior Service Costs Recognized		Derivative Instruments		Total
Affected Line in the Consolidated Statement of Operations:
Net revenue	$	—	$	—	$	(0.1)	$	(0.1)
Cost of goods sold	—		—		(0.4)		(0.4)

Other income (expense), net	0.6		—		—		0.6
Total before tax	$	0.6	$	—	$	(0.5)	$	0.1
Tax benefit							—
Total reclassifications for the period, net of tax							$	0.1

	Nine Months Ended June 30, 2019
	Amortization of Pension and Postretirement ⁽¹⁾						Loss (Gain) on
	Net Loss Recognized		Prior Service Costs Recognized		Derivative Instruments		Total
Affected Line in the Consolidated Statement of Operations:
Net revenue	$	—	$	—	$	0.1	$	0.1
Cost of goods sold	—		—		(0.6)		(0.6)

Other income (expense), net	1.3		—		—		1.3
Total before tax	$	1.3	$	—	$	(0.5)	$	0.8
Tax benefit							(0.2)
Total reclassifications for the period, net of tax							$	0.6

⁽¹⁾These accumulated other comprehensive loss components are included in the computation of net periodic pension cost (see Note 9).

13.Share-Based Compensation


	Three Months Ended June 30,						Nine Months Ended June 30,
	2020		2019		2020		2019
Share-based compensation costs	$	3.7	$	2.9	$	9.4	$	8.7
Less impact of income tax benefit	0.9		0.7		2.2		2.0
Share-based compensation costs, net of tax	$	2.8	$	2.2	$	7.2	$	6.7

The Company has share-based compensation with long-term performance-based metrics that are contingent upon the Company’s relative total shareholder return and the creation of shareholder value. Relative total shareholder return is determined by comparing the Company’s total shareholder return during a three-year period to the respective total shareholder returns of companies in a designated performance peer group or stock index, as applicable. Creation of shareholder value is measured by the cumulative cash returns and final period net operating profit after tax compared to the established hurdle rate over a three-year period. For the performance-based awards contingent upon the creation of shareholder value, compensation expense is adjusted each quarter based upon actual results to date and any changes to forecasted information on each of the separate grants.

During the nine months ended June 30, 2020, the Company made the following grants:

Table of Contents


			Number of Units
Stock options			454,929
Time-based stock awards			369,193
Performance-based stock awards (maximum that can be earned)			428,026

Stock options granted during 2020 had a weighted-average exercise price of $31.94 and a weighted-average grant date fair value of $6.63. The Company’s time-based stock awards and performance-based stock awards granted during the nine months ended June 30, 2020 had weighted-average grant date fair values of $31.31 and $32.73, respectively. Included in the performance-based stock awards granted during the nine months ended June 30, 2020 are 252,406 units whose payout level is based upon the Company’s relative total shareholder return over the three-year measurement period, as described above. These units will be expensed on a straight-line basis over the measurement period and are not subsequently adjusted after the grant date.

14.Other Income (Expense), Net


	Three Months Ended June 30,						Nine Months Ended June 30,
	2020		2019		2020		2019
Net loss on divestiture	$	—	$	—	$	(3.0)	$	—
Interest income	0.6		0.3		2.5		0.7
Foreign currency exchange gain (loss) , net	0.3		(0.5)		2.2		—
Other, net	(0.3)		(0.3)		0.1		(0.6)
Other income (expense), net	$	0.6	$	(0.5)	$	1.8	$	0.1

15.Commitments and Contingencies

Like most companies, Hillenbrand is involved from time to time in claims, lawsuits, and government proceedings relating to its operations, including environmental, patent infringement, business practices, commercial transactions, product and general liability, workers’ compensation, auto liability, employment, and other matters. The ultimate outcome of these matters cannot be predicted with certainty. An estimated loss from these contingencies is recognized when the Company believes it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated; however, it is difficult to measure the actual loss that might be incurred related to these matters. If a loss is not considered probable and/or cannot be reasonably estimated, the Company is required to make a disclosure if there is at least a reasonable possibility that a significant loss may have been incurred. Legal fees associated with claims and lawsuits are generally expensed as incurred.

Claims covered by insurance have in most instances deductibles and self-funded retentions up to $0.5 per occurrence or per claim, depending upon the type of coverage and policy period. For auto, workers compensation, and general liability claims in the U.S., outside insurance companies and third-party claims administrators generally assist in establishing individual claim reserves. An independent outside actuary provides estimates of ultimate projected losses, including incurred but not reported claims, which are used to establish reserves for losses. For all other types of claims, reserves are established based upon advice from internal and external counsel and historical settlement information for claims when such amounts are considered probable of payment.

The recorded amounts represent the best estimate of the costs that the Company will incur in relation to such exposures, but it is possible that actual costs will differ from those estimates.

16.Fair Value Measurements

Fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. The authoritative guidance establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are from sources independent of the Company. Unobservable inputs reflect the Company’s assumptions about the factors market participants would use in valuing the asset or liability, developed based upon the best information available in the circumstances. The categorization of financial assets and liabilities within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The hierarchy is broken down into three levels:

Table of Contents


Level 1:			Inputs are quoted prices in active markets for identical assets or liabilities.
Level 2:			Inputs include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, and inputs (other than quoted prices) that are observable for the asset or liability, either directly or indirectly.
Level 3:			Inputs are unobservable for the asset or liability.


	Carrying Value at June 30, 2020		Fair Value at June 30, 2020 Using Inputs Considered as:
					Level 1			Level 2			Level 3
Assets:
Cash and cash equivalents	$	263.1	$	263.1		$	—		$	—
Investments in rabbi trust	3.8		3.8			—			—
Derivative instruments	2.7		—			2.7			—

Liabilities:

$500.0 term loan	481.3		—			481.3			—
$400.0 senior unsecured notes	400.0		414.7			—			—
$375.0 senior unsecured notes	374.5		384.5			—			—
$225.0 term loan	216.6		—			216.6			—
$150.0 senior unsecured notes	150.0		149.7			—			—
$100.0 Series A Notes	100.0		—			101.1			—
Derivative instruments	6.3		—			6.3			—


	Carrying Value at September 30, 2019		Fair Value at September 30, 2019 Using Inputs Considered as:
					Level 1			Level 2			Level 3
Assets:
Cash and cash equivalents	$	399.0	$	399.0		$	—		$	—
Investments in rabbi trust	4.2		4.2			—			—
Derivative instruments	2.5		—			2.5			—

Liabilities:
$375.0 senior unsecured notes	374.4		380.6			—			—
$150.0 senior unsecured notes	149.9		152.8			—			—

$100.0 Series A Notes	100.0		—			108.5			—
Derivative instruments	2.6		—			2.6			—

Valuation Techniques

•Cash and cash equivalents and investments in rabbi trust are classified within Level 1 of the fair value hierarchy. Financial instruments classified as Level 1 are based on quoted market prices in active markets. The types of financial instruments the Company classifies within Level 1 include most bank deposits, money market securities, and publicly traded mutual funds. The Company does not adjust the quoted market price for such financial instruments.

•The Company estimates the fair value of foreign currency derivatives using industry accepted models. The significant Level 2 inputs used in the valuation of derivatives include spot rates, forward rates, and volatility. These inputs were obtained from pricing services, broker quotes, and other sources.

•The fair value of the amounts outstanding under the Term Loan Facilities approximate carrying value, as the Company believes their variable interest rate terms correspond to current market terms.

Table of Contents

•The fair values of the Series A Notes were estimated based on internally-developed models, using current market interest rate data for similar issues, as there is no active market for the Series A Notes.

•The fair values of the $400.0, $375.0, and $150.0 senior unsecured notes were based on quoted prices in active markets.

Derivative instruments

The Company has hedging programs in place to manage its currency exposures. The objectives of the Company’s hedging programs are to mitigate exposures in gross margin and non-functional-currency-denominated assets and liabilities. Under these programs, the Company uses derivative financial instruments to manage the economic impact of fluctuations in currency exchange rates. These include foreign currency exchange forward contracts, which generally have terms up to 24 months. The aggregate notional value of derivatives was $238.2 and $128.9 at June 30, 2020 and September 30, 2019, respectively. The derivatives are recorded at fair value primarily in other current assets and other current liabilities in the Consolidated Balance Sheets.

17.Segment and Geographical Information

Prior to completing the acquisition of Milacron on November 21, 2019, the Company conducted operations through two reportable operating segments: the Process Equipment Group and Batesville. Upon completing the acquisition, the Company has been undertaking a planning process of assessing its management and organizational structure. As of June 30, 2020, the Company is still assessing changes in its internal management reporting structure to incorporate Milacron and the effects it may have on the Company’s reportable segments, if any. Because this process was not complete as of June 30, 2020, the Company has reported the results of operations of Milacron from the acquisition date through June 30, 2020 as a separate reportable segment.

The Company records the direct costs of business operations to the reportable operating segments, including stock-based compensation, asset impairments, restructuring activities, and business acquisition costs. Corporate provides management and administrative services to each reportable segment. These services include treasury management, human resources, legal, business development, and other public company support functions such as internal audit, investor relations, financial reporting, and tax compliance. With limited exception for certain professional services and back-office and technology costs, the Company does not allocate these types of corporate expenses to the reportable segments.

Table of Contents

The following tables present financial information for the Company’s reportable segments and significant geographical locations:


	Three Months Ended June 30,						Nine Months Ended June 30,
	2020		2019		2020		2019
Net revenue
Process Equipment Group	$	281.3	$	315.3	$	899.0	$	924.2
Milacron	186.3		—		518.6		—
Batesville	139.9		131.3		405.7		397.3
Total	$	607.5	$	446.6	$	1,823.3	$	1,321.5

Adjusted EBITDA ⁽¹⁾
Process Equipment Group	$	57.6	$	54.9	$	166.6	$	156.6
Milacron	38.1		—		96.4		—
Batesville	36.4		25.3		91.4		83.6
Corporate	(11.1)		(10.7)		(30.9)		(31.7)

Net revenue ⁽²⁾
United States	$	292.1	$	222.1	$	853.0	$	669.3
Germany	151.2		145.4		495.2		398.3


All other foreign business units	164.2		79.1		475.1		253.9
Total	$	607.5	$	446.6	$	1,823.3	$	1,321.5

⁽¹⁾Adjusted EBITDA is a non-GAAP measure used by management to measure segment performance and make operating decisions. See the Operating Performance Measures section of Management’s Discussion and Analysis for further information on adjusted EBITDA, which is reconciled to consolidated net income (loss) below.

⁽²⁾The Company attributes net revenue to a geography based upon the location of the business that consummates the external sale.


	June 30, 2020		September 30, 2019
Total assets assigned
Process Equipment Group	$	1,710.4	$	1,729.1
Milacron	1,988.0		—
Batesville	228.7		186.1
Corporate	102.8		313.4
Total	$	4,029.9	$	2,228.6

Tangible long-lived assets, net⁽¹⁾
United States	$	208.0	$	75.8
Germany	103.2		40.2
China	51.4		4.4

All other foreign business units	130.4		19.9
Total	$	493.0	$	140.3

⁽¹⁾Tangible long-lived assets, net includes operating lease right-of-use assets as of June 30, 2020 due to the adoption of ASU 2016-02 in the current year.

Table of Contents

The following schedule reconciles reportable segment adjusted EBITDA to consolidated net income (loss):


	Three Months Ended June 30,						Nine Months Ended June 30,
	2020		2019		2020		2019
Adjusted EBITDA:
Process Equipment Group	$	57.6	$	54.9	$	166.6	$	156.6
Milacron	38.1		—		96.4		—
Batesville	36.4		25.3		91.4		83.6
Corporate	(11.1)		(10.7)		(30.9)		(31.7)
Less:
Interest income	(0.6)		(0.3)		(2.5)		(0.7)
Interest expense	19.7		5.2		55.3		16.1
Income tax expense	28.3		11.6		17.7		39.9
Depreciation and amortization	33.9		15.1		98.4		44.3
Impairment charges	—		—		82.5		—
Business acquisition, disposition, and integration costs	5.5		3.8		67.3		4.9
Restructuring and restructuring-related charges	3.6		2.4		6.7		3.6
Inventory step-up	3.6		—		40.7		0.2
Net loss on divestiture	—		—		3.0		—
Other	2.0		—		2.4		—
Consolidated net income (loss)	$	25.0	$	31.7	$	(48.0)	$	100.2

Table of Contents

18.Restructuring

The following schedule details the restructuring charges by reportable segment and the classification of those charges in the Consolidated Statements of Operations.


	Three Months Ended June 30, 2020										Three Months Ended June 30, 2019
	Cost of goods sold		Operating expenses		Total		Cost of goods sold		Operating expenses		Total
Process Equipment Group	$	0.2	$	1.9	$	2.1	$	0.2	$	0.4	$	0.6
Milacron	0.8		0.1		0.9		—		—		—
Batesville	(0.1)		0.1		—		0.3		1.4		1.7
Corporate	—		0.4		0.4		—		—		—
Total	$	0.9	$	2.5	$	3.4	$	0.5	$	1.8	$	2.3

	Nine Months Ended June 30, 2020										Nine Months Ended June 30, 2019
	Cost of goods sold		Operating expenses		Total		Cost of goods sold		Operating expenses		Total
Process Equipment Group	$	0.9	$	3.1	$	4.0	$	0.6	$	0.5	$	1.1
Milacron	0.6		1.3		1.9		—		—		—
Batesville	—		0.5		0.5		0.5		1.9		2.4
Corporate	—		1.4		1.4		—		—		—
Total	$	1.5	$	6.3	$	7.8	$	1.1	$	2.4	$	3.5

The restructuring charges during the three and nine months ended June 30, 2020 and 2019 related primarily to severance costs. The severance costs within the Milacron and Corporate reportable segments were primarily related to the ongoing integration of Milacron. At June 30, 2020, $4.0 of restructuring costs were accrued and expected to be paid over the next twelve months.

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF

OPERATIONS

(financial amounts in millions, except share and per share data, throughout Management’s Discussion and Analysis)

FORWARD-LOOKING STATEMENTS AND FACTORS THAT MAY AFFECT FUTURE RESULTS

Throughout this Form 10-Q, we make a number of “forward-looking statements” that are within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, and that are intended to be covered by the safe harbor provided under these sections. As the words imply, these are statements about future sales, earnings, cash flow, results of operations, uses of cash, financings, share repurchases, ability to meet deleveraging goals, and other measures of financial performance or potential future plans or events, strategies, objectives, beliefs, prospects, assumptions, expectations, and projected costs or savings or transactions of the Company that might or might not happen in the future, as contrasted with historical information. Forward-looking statements are based on assumptions that we believe are reasonable, but by their very nature are subject to a wide range of risks. If our assumptions prove inaccurate or unknown risks and uncertainties materialize, actual results could vary materially from Hillenbrand’s expectations and projections.

Accordingly, in this Form 10-Q, we may say something like:

“We expect that future revenue associated with the Process Equipment Group will be influenced by order backlog.”

That is a forward-looking statement, as indicated by the word “expect” and by the clear meaning of the sentence.

Other words that could indicate we are making forward-looking statements include:

Table of Contents

intend

believe

plan

expect

may

goal

would

project

become

pursue

estimate

will

forecast

continue

could

anticipate

target

impact

promise

improve

progress

potential

should

This is not an exhaustive list, but is intended to give you an idea of how we try to identify forward-looking statements. The absence of any of these words, however, does not mean that the statement is not forward-looking.

Here is the key point: Forward-looking statements are not guarantees of future performance, and our actual results could differ materially from those set forth in any forward-looking statements.

Any number of factors, many of which are beyond our control, could cause our performance to differ significantly from what is described in the forward-looking statements. This includes risks related to the ongoing COVID-19 pandemic and the societal, governmental, and individual responses thereto, including supply chain disruptions; loss of contracts and/or customers; erosion of some customers’ credit quality; downgrades of the Company’s credit quality; closure or temporary interruption of the Company’s or suppliers’ manufacturing facilities; travel, shipping and logistical disruptions; loss of human capital or personnel, and general economic calamities, in addition to a variety of risks related to our acquisition and integration of Milacron. For a discussion of factors that could cause actual results to differ from those contained in forward-looking statements, see the discussions under the heading “Risk Factors” in Item 1A of Part I of the Company’s Form 10-K filed with the SEC on November 13, 2019, and in Item 1A of Part II of this Form 10-Q, as well as other risks and uncertainties detailed in our other filings with the SEC from time to time. The forward-looking information in this Form 10-Q speaks only as of the date covered by this report, and we assume no obligation to update or revise any forward-looking statements.

EXECUTIVE OVERVIEW

Hillenbrand is a global diversified industrial company with multiple leading brands that serve a wide variety of industries around the world. Hillenbrand’s portfolio is composed of three reportable operating segments: the Process Equipment Group, Milacron®, and Batesville®. The Process Equipment Group businesses design, develop, manufacture, and service highly engineered industrial equipment around the world. Milacron is a global leader in highly engineered and customized systems in plastic technology and processing. Batesville is a recognized leader in the death care industry in North America.

We strive to provide superior return for our shareholders, exceptional value for our customers, great professional opportunities for our employees, and to be responsible to our communities through deployment of the HOM. The HOM is a consistent and repeatable framework designed to produce sustainable and predictable results. The HOM describes our mission, vision, values, and mindset as leaders; applies our management practices in Strategy Management, Segmentation, Lean, Talent Development, and Acquisitions; and prescribes three steps (Understand, Focus, and Grow) designed to make our businesses both bigger and better. Our goal is to continue developing Hillenbrand as a world-class global diversified industrial company through the deployment of the HOM.

Our strategy is to leverage our historically strong financial foundation and the implementation of the HOM to deliver sustainable profit growth, revenue expansion, and substantial free cash flow and then reinvest available cash in new growth initiatives that are focused on building platforms with leadership positions in our core markets and near adjacencies, both organically and inorganically, in order to create shareholder value.

During the three and nine months ended June 30, 2020, the following operational decisions and economic developments had an impact on our current and future cash flows, results of operations, and financial position.

COVID-19 Impact

On March 11, 2020, the World Health Organization categorized the outbreak of the novel coronavirus (“COVID-19”) as a pandemic, and the virus continues to spread throughout the United States and other countries across the world. To limit the spread of COVID-19, national and local governments around the world have instituted certain measures, including travel restrictions, business curtailments, shelter-in-place orders and social distancing guidelines.

COVID-19 is impacting Hillenbrand very differently by business, geography, and function. The scope and nature of these impacts continue to evolve each day. We have experienced an adverse impact on our sales, consolidated results of operations, and cash flows during the three and nine months ended June 30, 2020. It is too early to quantify the impact for the remainder of our fiscal year ended September 30, 2020 or beyond, but the actions being undertaken to reduce the spread of COVID-19 are currently creating disruptions, and are likely to continue to create significant disruptions, with respect to consumer demand, our

Table of Contents

ability to continue to manufacture products, and the reliability of our supply chain. Accordingly, management is continually evaluating the Company’s liquidity position, communicating with and monitoring the actions of our customers and suppliers, and reviewing our near- and longer-term financial performance as we manage the Company through the uncertainty related to COVID-19.

We cannot reasonably estimate the duration, spread or severity of this pandemic; however, as a result of the current circumstances, we expect to continue to experience an adverse impact during the remainder of fiscal 2020, including the potential for impairment of certain intangible and other long-lived assets, in addition to the impairment charges that were recorded in the second quarter of 2020. Should these conditions continue into fiscal 2021, the Company would similarly expect an adverse impact on its net revenue, consolidated results of operations, and cash flows in such year, depending upon the severity and length of time such conditions persist.

We continue to take actions intended to help minimize the risk to our company, employees, customers, and the communities in which we operate, as well as lessen the financial impact on the business while protecting our ability to continue to generate profitable growth over the long term. Among these are proactive measures aimed at mitigating the financial impact of COVID-19 and preserving liquidity, including:

•Voluntary reduction in CEO base salary by 30% through at least the end of the fiscal year;

•Voluntary waiver by the Board of Directors of its scheduled cash compensation increase for 2020;

•Cancellation of all regularly scheduled merit-based salary increases for salaried US- and Canada-based employees for 2020;

•Suspension of all hiring for exempt and nonexempt positions, except for critical positions;

•Reduction in capital spend while continuing to invest in high-return projects and prioritizing critical maintenance, safety, and regulatory projects;

•Employee furloughs and reduced work arrangements at several Company locations due to lower demand, which impacted approximately 15% of employees; and

•The Company’s share repurchase program remains suspended.

While we anticipate that the foregoing measures are temporary, we cannot predict the specific duration for which these precautionary measures will stay in effect, and we may elect or need to take additional measures as the information available to us continues to develop, including with respect to our employees, customers, and our relationships with our third-party vendors.

In addition, we have taken proactive measures to maintain financial flexibility within the landscape of the COVID-19 pandemic. We believe the Company has sufficient liquidity to operate in the current business environment as a result of these actions. Hillenbrand increased cash holdings over the past two quarters (from December 31, 2019 to June 30, 2020) by $120.7, primarily with a portion of the cash proceeds from the issuance of $400.0 in senior unsecured notes in June 2020 and the sale of the Cimcool business in March 2020. Additionally, we amended the Credit Agreement on May 19, 2020 to, among other things, increase the maximum permitted leverage ratio for current and future quarters. As of June 30, 2020, Hillenbrand was in full compliance with all covenants under the Credit Agreement, and as of that date, it had liquidity of approximately $905.5, including $263.1 in cash on hand and $642.4 of borrowing capacity immediately available under the Revolver. We continue to evaluate additional measures to maintain financial flexibility and support general working capital requirements as a result of the COVID-19 pandemic. See Note 8 included in Part 1, Item 1 of this Form 10-Q for further details on all financing activity that occurred during the quarter ended June 30, 2020.

Employee Safety and Health

We have implemented a number of employee safety measures across our plants and other locations in an attempt to contain the spread of COVID-19. Such actions have included:

•Initiated regular communication regarding impacts of the COVID-19 pandemic, including health and safety protocols and procedures;

•Required telework for those employees who can conduct their work remotely;

•Implemented temperature screening of employees at the majority of manufacturing facilities;

•Instituted additional sanitization protocols, including increased frequency of disinfecting high-traffic areas;

•Established new physical distancing procedures for employees who need to be onsite;

•Provided additional personal protective equipment and cleaning supplies;

•Modified work spaces with plexiglass and touchless faucets;

•Implemented protocols to address actual and suspected COVID-19 cases and exposure; and

•Prohibited all domestic and international non-essential travel for all employees.

Table of Contents

Customer Focus

Our customer service, sales, and engineering teams are working closely with customers to meet current demand. Sales and engineering teams are meeting with customers remotely via video calls to continue the design and specification process that would have previously been held in-person. Call centers remain operational through remote call-in.

Business Continuity

While a number of our plants are operating as essential businesses, as determined by the jurisdictions in which we operate, we have experienced disruptions at some smaller facilities in locations such as India as we take actions to comply with the temporary government restrictions related to the COVID-19 pandemic. We expect that these impacted facilities will account for approximately 5% of the Company’s projected annual consolidated revenue. These facilities were closed or operating at reduced capacity at various times during the quarter ended June 30, 2020, but all significant facilities were operating at or near normal production levels as of the date of this filing. While the Company’s manufacturing plants in China were closed for part of the quarter ended March 31, 2020, they were running at or near full capacity by late March. Many of the Company’s non-production employees were working remotely as of the date of this filing.

We are closely monitoring the supply chain and taking actions as needed to mitigate disruptions. We continue to work closely with our suppliers and customers to preserve business continuity and meet current demand. We are capitalizing on our global manufacturing footprint and flexible supply chains to move production to different regions of the world as needed. As of the date of this filing the Company has not experienced any major shortages in our supply chain. For the quarter ended June 30, 2020, order intake at the Process Equipment Group and Milacron segments was negatively impacted by the COVID-19 pandemic and decreased sequentially from the quarter ended March 31, 2020, primarily due to softening in the markets as customers are delaying their decision-making process; however, we have not seen significant order cancellations as of the date of this filing. Batesville experienced higher demand for burial caskets in certain geographical areas starting in late March, and that higher demand continued throughout the quarter ended June 30, 2020. That higher demand resulted in a strong year-over-year sales increase at Batesville for the quarter ended June 30, 2020, partially offset by an estimated increased rate at which families opted for cremation. Given the uncertainty related to COVID-19, we cannot predict the potential further magnitude or duration of these developments and the impact they will have on our financial results and cash flows for the remainder of fiscal 2020 and at least the first half of fiscal 2021. In addition to the actions taken as of the date of this filing as discussed above, further actions may be taken in certain businesses in response to continued lower customer demand, including temporary reductions in work hours, furloughs, or layoffs, if required.

Government Updates

On March 27, 2020, the U.S. government enacted the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”). The CARES Act, among other things, includes provisions relating to refundable payroll tax credits, deferment of employer side social security payments, net operating loss carryback periods, alternative minimum tax credit refunds, modifications to the net interest deduction limitations and technical corrections to tax depreciation methods for qualified improvement property, as well as loans to certain qualifying businesses. We continue to examine the impacts that the CARES Act may have on our business. While we may take advantage of certain of the CARES Act’s cash deferral provisions, many of the provisions are not applicable to us. As of the date of this filing, we have not participated in CARES Act loans.

Additionally, we continue to monitor the COVID-19 legislative activity of many of the other countries in which we operate. As is the case in the United States, many provisions of the legislation enacted outside the United States are not applicable to us at this time.

Except as specifically identified in this report, events and changes in circumstances arising after the quarter ended June 30, 2020, including those resulting from the impact of COVID-19, will be reflected in management’s estimates for future periods in subsequent periodic filings. For further discussion of management’s estimates, refer to Note 1 in Part 1, Item 1 of this report. For further discussion of the COVID-19 pandemic, refer to “Item 1A. Risk Factors” in Part II of this report.

Acquisition of Milacron

As discussed in Note 4 of Part I, Item 1 of this Form 10-Q, on November 21, 2019, we completed the acquisition of Milacron for a total purchase price of approximately $2.0 billion through a merger of our wholly-owned subsidiary with and into Milacron, resulting in ownership of 100% of Milacron common stock. Milacron is a global leader in highly engineered and customized systems in plastic technology and processing. The acquisition provides Hillenbrand with increased scale and

Table of Contents

meaningful product diversification, enhancing its ability to serve customers with expanded capabilities across the plastics value chain. The results of Milacron are currently reported separately in its own reportable segment. The Consolidated Financial Statements include the financial results of Milacron from the date of acquisition.

As a result of the acquisition, Milacron stockholders received $11.80 in cash per share and a fixed exchange ratio of 0.1612 shares of Hillenbrand common stock for each share of Milacron common stock they owned, with cash paid in lieu of fractional shares. In addition, concurrent with the closing of the acquisition, we made a cash payment of $772.9 to repay outstanding Milacron debt, including accrued interest. The Company funded the acquisition through a combination of cash on hand, new debt financing, and the issuance of common stock. See Note 8 of Part I, Item 1 of this Form 10-Q for a discussion of the debt financing.

The Company’s results for the period since the acquisition were significantly impacted by the non-recurring effects of the fair value adjustments to inventories and backlog required by acquisition accounting. These fair value adjustments are being charged to the Consolidated Statements of Operations over the respective periods that inventory is expected to be consumed and backlog is expected to be realized as revenue. The preliminary fair value assigned to Milacron’s backlog was $10.0, which was fully amortized as expense during the nine months ended June 30, 2020. The preliminary step-up adjustment to inventories was $40.7, which was fully charged as expense during the nine months ended June 30, 2020 ($3.6 of expense during the three months ended June 30, 2020).

The preliminary fair value assigned to Milacron’s customer relationships, trade names, and technology totaled $805.0, of which $125.0 was related to the Cimcool business that was divested in the second quarter of 2020. The trade names were designated as indefinite-lived intangible assets while the customer relationships and technology are amortized over their respective estimated useful lives on a straight-line basis, which will result in approximately $9.0 of amortization expense during the remaining three months of 2020. The acquisition resulted in preliminary goodwill of $707.6.

Divestiture of Cimcool

On March 30, 2020, we completed the sale of the Company’s Cimcool (“Cimcool”) business, which represented the former Fluids Technologies reportable segment of Milacron before its acquisition by the Company, to DuBois Chemicals, Inc. The sale resulted in cash proceeds received at closing of $222.4, net of cash divested. Consistent with our current capital allocation priorities, we used a portion of the cash proceeds from the sale for repayments on the Revolver during the quarter ended March 31, 2020, and intend to use the remainder for general working capital purposes.

In addition, we may receive contingent consideration of up to an aggregate of $26.0 based on multiple earn-out provisions. As of the transaction date (and at June 30, 2020), we were unable to determine that it was probable that any of the contingent consideration would be received, and accordingly no asset was recorded for contingent consideration.

As a result of the sale, we recorded a pre-tax loss of $3.0 within other income (expense), net in the Consolidated Statement of Operations during the nine months ended June 30, 2020. The related tax effect resulted in tax expense of $13.0 and was included within income tax expense in the Consolidated Statement of Operations during the nine months ended June 30, 2020. We incurred $0.4 and $4.2 of transaction costs associated with the sale during the three and nine months ended June 30, 2020, respectively, which were recorded within operating expenses in the Consolidated Statements of Operations.

We determined that the sale of Cimcool did not represent a strategic shift that had or will have a major effect on our consolidated results of operations, and therefore, Cimcool was not classified as a discontinued operation. Cimcool’s results of operations were included within the Milacron reportable segment until the completion of the sale on March 30, 2020.

OPERATING PERFORMANCE MEASURES

The following discussion compares our results for the three and nine months ended June 30, 2020, to the same period in 2019. The Company’s fiscal year ends on September 30. Unless otherwise stated, references to years relate to fiscal years. We begin the discussion at a consolidated level and then provide separate detail about the Process Equipment Group, Milacron, Batesville, and Corporate. These results of operations are prepared in accordance with United States generally accepted accounting principles (“GAAP”).

We also provide certain non-GAAP operating performance measures. These non-GAAP measures are referred to as “adjusted” measures and primarily exclude the following items:

•business acquisitions, disposition, and integration costs;

Table of Contents

•restructuring and restructuring-related charges;

•impairment charges;

•inventory step-up charges;

•debt financing activities related to the acquisition of Milacron;

•net loss on divestiture of Cimcool;

•COVID-19 pandemic-related costs;

•the related income tax impact for all of these items; and

•non-recurring tax benefits and expenses related to the interaction of certain provisions of the Tax Act and certain tax items related to the acquisition of Milacron and divestiture of Cimcool.

Non-GAAP information is provided as a supplement, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP.

We use this non-GAAP information internally to make operating decisions and believe it is helpful to investors because it allows more meaningful period-to-period comparisons of our ongoing operating results. The information can also be used to perform trend analysis and to better identify operating trends that may otherwise be masked or distorted by items such as the above excluded items. We believe this information provides a higher degree of transparency.

An important non-GAAP measure that we use is adjusted earnings before interest, income tax, depreciation, and amortization

(“adjusted EBITDA”). A part of Hillenbrand’s strategy is to selectively acquire companies that we believe can benefit from the HOM to spur faster and more profitable growth. Given that strategy, it is a natural consequence to incur related expenses, such as amortization from acquired intangible assets and additional interest expense from debt-funded acquisitions. Accordingly, we use adjusted EBITDA, among other measures, to monitor our business performance. Adjusted EBITDA is not a recognized term under GAAP and therefore does not purport to be an alternative to net income (loss). Further, the Company’s measure of adjusted EBITDA may not be comparable to similarly titled measures of other companies.

Another important non-GAAP operational measure used is backlog. Backlog is not a term recognized under GAAP; however, it is a common measurement used in industries with extended lead times for order fulfillment, like those in which the Process Equipment Group and Milacron compete. Backlog represents the amount of net revenue that we expect to realize on contracts awarded related to the Process Equipment Group and Milacron. For purposes of calculating backlog, 100% of estimated net revenue attributable to consolidated subsidiaries is included. Backlog includes expected revenue from large systems and equipment, as well as replacement parts, components, and service. The length of time that projects remain in backlog can span from days for replacement parts or service to approximately 18 to 24 months for larger system sales within the Process Equipment Group. The majority of the backlog within Milacron is expected to be fulfilled within the next twelve months. Backlog includes expected net revenue from the remaining portion of firm orders not yet completed, as well as net revenue from change orders to the extent that they are reasonably expected to be realized. We include in backlog the full contract award, including awards subject to further customer approvals, which we expect to result in net revenue in future periods. In accordance with industry practice, our contracts may include provisions for cancellation, termination or suspension at the discretion of the customer.

We expect that future revenue associated with the Process Equipment Group and Milacron will be influenced by backlog because of the lead time involved in fulfilling engineered-to-order equipment for customers. Although backlog can be an indicator of future net revenue, it does not include projects and parts orders that are booked and shipped within the same quarter. The timing of order placement, size, extent of customization, and customer delivery dates can create fluctuations in backlog and revenue. Net revenue attributable to backlog may also be affected by foreign exchange fluctuations for orders denominated in currencies other than U.S. dollars.

We calculate the foreign currency impact on net revenue, gross profit, operating expenses, backlog, consolidated net income (loss), and adjusted EBITDA in order to better measure the comparability of results between periods. We calculate the foreign currency impact by translating current year results at prior year foreign exchange rates. This information is provided because exchange rates can distort the underlying change in these metrics, either positively or negatively. The cost structures for Corporate and Batesville are generally not significantly impacted by the fluctuation in foreign exchange rates, and we do not disclose the foreign currency impact in the Operations Review section below where the impact is not significant.

See page 48 for a reconciliation of adjusted EBITDA to consolidated net income (loss), the most directly comparable GAAP measure. We use other non-GAAP measures in certain other instances and include information reconciling such non-GAAP measures to the respective most directly comparable GAAP measures. Given that there is no GAAP financial measure comparable to backlog, a quantitative reconciliation is not provided.

Table of Contents

CRITICAL ACCOUNTING ESTIMATES

For the three and nine months ended June 30, 2020, there were no significant changes to our critical accounting estimates, as outlined in our Annual Report on Form 10-K for 2019.

OPERATIONS REVIEW — CONSOLIDATED


	Three Months Ended June 30,											Nine Months Ended June 30,
	2020					2019				2020			2019
	Amount		% of Net Revenue	Amount		% of Net Revenue	Amount		% of Net Revenue	Amount		% of Net Revenue
Net revenue	$	607.5	100.0	$	446.6	100.0	$	1,823.3	100.0	$	1,321.5	100.0
Gross profit	207.3		34.1	148.4		33.2	572.8		31.4	456.3		34.5
Operating expenses	118.5		19.5	90.8		20.3	411.9		22.6	275.2		20.8
Amortization expense	16.4		2.7	8.6		1.9	55.2		3.0	25.0		1.9
Impairment charges	—		—	—		—	82.5		4.5	—		—
Interest expense	19.7		3.2	5.2		1.2	55.3		3.0	16.1		1.2
Other income (expense), net	0.6		(0.1)	(0.5)		0.1	1.8		(0.1)	0.1		—
Income tax expense	28.3		4.7	11.6		2.6	17.7		1.0	39.9		3.0
Net income (loss) attributable
to Hillenbrand	24.0		4.0	30.4		6.8	(53.1)		(2.9)	96.7		7.3

We are actively monitoring the impact of the COVID-19 pandemic, which we expect to create continued economic uncertainty for our fourth quarter ended September 30, 2020 and likely beyond. Cost containment actions taken as a result of the COVID-19 pandemic are expected to be temporary; we do not anticipate them to continue to the same extent as implemented during the current fiscal year.

Hillenbrand is on track to realize the targeted year-one cost synergies related to the Milacron acquisition of $20.0 to $25.0 within the current fiscal year, and the Company now expects to generate annual run rate cost synergies of $75.0 within three years of the transaction close, a 50% increase from the original target of $50.0.

Three Months Ended June 30, 2020 Compared to Three Months Ended June 30, 2019

Net revenue increased $160.9 (36%), which included unfavorable foreign currency impact (1%).

•The Process Equipment Group’s net revenue decreased $34.0 (11%), primarily due to a decrease in large systems sales in plastics largely driven by delays associated with the COVID-19 pandemic, and a decrease in demand for parts and service and other capital equipment, partially offset by favorable pricing. Foreign currency impact decreased net revenue by 1%.

•Milacron contributed net revenue of $186.3 during the three months ended June 30, 2020.

•Batesville’s net revenue increased $8.6 (7%), primarily due to an increase in volume (8%), partially offset by a decline in average selling price (1%). Higher volume was driven by an increase in burial casket sales primarily due to estimated higher deaths from the COVID-19 pandemic, partially offset by an estimated increased rate at which families opted for cremation.

Gross profit increased $58.9 (40%) and gross profit margin improved 90 basis points to 34.1%. Gross profit included inventory step-up charges at Milacron of $3.6, restructuring and restructuring-related charges of $0.8, and costs associated with the COVID-19 pandemic of $0.8. Excluding these charges, adjusted gross profit margin improved 170 basis points to 35.0%.

•The Process Equipment Group’s gross profit decreased $3.8 (4%), primarily due to a decrease in large systems sales in plastics, largely driven by delays associated with the COVID-19 pandemic, a decline in demand for parts and service, and cost inflation, partially offset by pricing and productivity improvements, cost containment, and improved cost of quality. Foreign currency impact decreased gross profit by 1%. Gross profit margin improved 280 basis points to

Table of Contents

37.0% in 2020, primarily due to pricing and productivity improvements and a supplier quality issue in the prior year that did not repeat in the current year, partially offset by cost inflation.

The Process Equipment Group’s gross profit included restructuring and restructuring-related charges ($0.2 in 2020 and $0.2 in 2019). Excluding these charges, adjusted gross profit decreased $3.7 (3%) and adjusted gross profit margin improved 280 basis points to 37.1%.

•Milacron’s gross profit was $52.0 and gross profit margin was 27.9%. Milacron’s gross profit included inventory step-up charges of $3.6, restructuring and restructuring-related charges of $0.7, and costs associated with the COVID-19 pandemic of $0.6. Excluding these charges, adjusted gross profit margin was 30.5%.

•Batesville’s gross profit increased $10.7 (26%) and gross profit margin improved 580 basis points to 36.6%. The increase in gross profit and gross profit margin was primarily due to higher volume, productivity initiatives, and deflation in commodities and fuel, partially offset by inflation in wages and benefits.

Batesville’s gross profit included restructuring and restructuring-related charges of $0.3 in 2019 and costs associated with the COVID-19 pandemic of $0.2 in 2020. Excluding these charges, adjusted gross profit increased $10.5 (26%) and adjusted gross profit margin improved 560 basis points to 36.7%.

Operating expenses increased $27.7 (31%), primarily due to the addition of Milacron operating expenses ($32.3), increases in business acquisition, disposition, integration costs related to the acquisition of Milacron, and cost inflation, partially offset by productivity initiatives, cost containment actions, and a decrease in variable compensation. Foreign currency impact decreased operating expenses by 1%. Our operating expense-to-revenue ratio improved by 80 basis points to 19.5% in 2020. Operating expenses included the following items:


	Three Months Ended June 30,
	2020		2019
Business acquisition, disposition, and integration costs	$	5.4	$	3.8
Restructuring and restructuring-related charges	2.8		1.9
COVID-19 pandemic-related costs	1.1		—

On an adjusted basis, which excludes business acquisition, disposition, and integration costs, restructuring and restructuring-related charges, and costs associated with the COVID-19 pandemic, operating expenses increased $24.1 (28%). Adjusted operating expenses as a percentage of net revenue improved 110 basis points in 2020 to 18.0%.

Amortization expense increased $7.8 (91%), primarily due to amortization on the acquired intangible assets of Milacron ($9.1 in 2020).

Interest expense increased $14.5 (279%), primarily due to increased borrowings as a result of the Milacron acquisition. See Note 8 of Part I, Item 1 of this Form 10-Q for a discussion of the debt financing.

Other income (expense), net was $0.6 of income in 2020, compared to $0.5 of expense in 2019. The increase in other income was primarily due to increases in foreign currency exchange gains and interest income.

The effective tax rate was 53.1% in 2020 compared to 26.8% in 2019. The effective tax rate in the current quarter and the difference from the prior year is primarily due to the impact of Milacron carryforward tax attributes adversely impacting domestic taxes associated with the Tax Act, unfavorable geographic mix of income, and nondeductible acquisition expenses related to the Milacron acquisition.

The adjusted effective tax rate was 26.7% in 2020 compared to 26.6% in 2019. The adjusted effective income tax rate primarily excludes the impact of the following items:

•certain tax items related to the acquisition of Milacron, including:

◦the impact of Milacron carryforward tax attributes adversely impacting domestic taxes associated with the Tax Act ($7.2 tax expense in 2020);

◦the tax effect of nondeductible acquisition expenses ($2.3 tax expense in 2020); and

•the tax effect of adjustments to income (loss) before income taxes.

Table of Contents

Nine Months Ended June 30, 2020 Compared to Nine Months Ended June 30, 2019

Net revenue increased $501.8 (38%), which included unfavorable foreign currency impact (1%).

•The Process Equipment Group’s net revenue decreased $25.2 (3%), primarily due to a decline in demand for screening and separating equipment (including equipment that processes proppants for hydraulic fracturing), other capital equipment, and parts and service, partially offset by increased demand for large systems in plastics and favorable pricing. Foreign currency impact decreased net revenue by 2%.

•Milacron contributed net revenue of $518.6 since the acquisition date (November 21, 2019).

•Batesville’s net revenue increased $8.4 (2%), primarily due to an increase in volume (3%), partially offset by a decrease in average selling price (1%). Higher volume was driven by an increase in burial casket sales primarily due to estimated higher deaths from the COVID-19 pandemic, partially offset by an estimated increased rate at which families opted for cremation.

Gross profit increased $116.5 (26%), which included unfavorable foreign currency impact (1%). Gross profit margin decreased 310 basis points to 31.4%. Gross profit included inventory step-up charges at Milacron of $40.7, restructuring and restructuring-related charges of $1.5, and costs associated with the COVID-19 pandemic of $1.2. Excluding these charges, adjusted gross profit margin decreased 80 basis points to 33.8%.

•The Process Equipment Group’s gross profit decreased $6.3 (2%), primarily due to a decline in demand for screening and separating equipment (including equipment that processes proppants for hydraulic fracturing), cost inflation, and unfavorable mix due to an increased proportion of lower margin, large systems sales in plastics, partially offset by pricing and productivity improvements and an increase in volume of large systems sales in plastics. Foreign currency impact decreased gross profit by 1%. Gross profit margin improved 30 basis points to 35.4% in 2020 primarily due to pricing and productivity improvements, partially offset by cost inflation and an increased proportion of lower margin, large systems sales in plastics.

The Process Equipment Group’s gross profit included restructuring and restructuring-related charges ($0.9 in 2020 and $0.6 in 2019) and inventory step-up charges ($0.2 in 2019). Excluding these charges, adjusted gross profit decreased $6.0 (2%) and adjusted gross profit margin improved 30 basis points to 35.5%.

•Milacron’s gross profit was $116.9 and gross profit margin was 22.5% for the period since the acquisition date. Milacron’s gross profit included inventory step-up charges of $40.7, restructuring and restructuring-related charges of $0.5, and costs associated with the COVID-19 pandemic of $0.9. Excluding these charges, adjusted gross profit was $159.0 and adjusted gross profit margin was 30.7%.

•Batesville’s gross profit increased $5.9 (5%) and gross profit margin improved 80 basis points to 34.0%. The increase in gross profit and gross profit margin was primarily due to higher volume, productivity initiatives, and deflation in commodities and fuel, partially offset by inflation in wages and benefits.

Batesville’s gross profit included restructuring and restructuring-related charges of $0.5 in 2019, business acquisition, disposition, and integration costs of $0.2 in 2020, and costs associated with the COVID-19 pandemic of $0.2 in 2020. Excluding these charges, adjusted gross profit increased $5.8 (4%) and adjusted gross profit margin improved 80 basis points to 34.1%.

Operating expenses increased $136.7 (50%), primarily due to the addition of Milacron operating expenses ($97.7), increases in business acquisition, disposition, and integration costs related to the acquisition of Milacron and divestiture of Cimcool, an increase in restructuring and restructuring-related charges, and costs associated with the COVID-19 pandemic incurred in the current year, partially offset by productivity initiatives, cost containment actions, and a decrease in variable compensation. Foreign currency impact decreased operating expenses by 1%. Our operating expense-to-revenue ratio increased by 180 basis points to 22.6% in 2020. Operating expenses included the following items:

Table of Contents


	Nine Months Ended June 30,
	2020		2019
Business acquisition, disposition, and integration costs	$	66.8	$	4.9
Restructuring and restructuring-related charges	5.2		2.5
COVID-19 pandemic-related costs	1.1		—

On an adjusted basis, which excludes business acquisition, disposition, and integration costs, restructuring and restructuring-related charges, and costs associated with the COVID-19 pandemic, operating expenses increased $71.1 (27%). Adjusted operating expenses as a percentage of net revenue improved 170 basis points in 2020 to 18.6%.

Amortization expense increased $30.2 (121%), primarily due to amortization on the acquired intangible assets of Milacron ($33.2 in 2020).

Impairment charges were $82.5 due to goodwill and intangible asset impairments recorded in 2020. See Note 7 of Part I, Item 1 of this Form 10-Q for further information on the impairment charges.

Interest expense increased $39.2 (244%), primarily due to increased borrowings as a result of the Milacron acquisition. See Note 8 of Part I, Item 1 of this Form 10-Q for a discussion of the debt financing. On an adjusted basis, which primarily excludes $2.4 of interest expense on the $375.0 senior unsecured notes for the period prior to completing the acquisition of Milacron (October 1, 2019 through November 20, 2019), interest expense increased by $36.1 (224%).

Other income (expense), net was $1.8 of income in 2020, compared to $0.1 of income in 2019. The increase in other income was primarily due to increases in interest income and foreign currency exchange gains, partially offset by the $3.0 pre-tax loss on the divestiture of Cimcool in 2020.

The effective tax rate was (58.4)% in 2020 compared to 28.5% in 2019. Due to the current year net loss position, the effective tax rate decreased over the prior year primarily as a result of the discrete recognition of tax expense on the divestiture of Cimcool, the impact of Milacron carryforward tax attributes adversely impacting domestic taxes associated with the Tax Act, unfavorable geographic mix of income, and nondeductible acquisition expenses related to the Milacron acquisition, net of the tax benefit recognized in 2020 from the revaluation of current and deferred tax balances in connection with the enacted statutory tax rate reductions in certain foreign jurisdictions. The change in the effective tax rate compared to the prior year was also impacted by the prior year increase in the reserve for unrecognized tax benefits that did not recur in the current year.

The adjusted effective tax rate was 25.8% in 2020 compared to 27.0% in 2019. The adjusted effective income tax rate primarily excludes the impact of the following items:

•the tax effect on the divestiture of Cimcool ($13.0 tax expense in 2020);

•certain tax items related to the acquisition of Milacron, including:

◦the tax effect of Milacron carryforward tax attributes adversely impacting domestic taxes associated with the Tax Act ($9.7 tax expense in 2020);

◦the revaluation of deferred tax balances in connection with enacted statutory tax rate reductions in certain foreign jurisdictions ($6.7 tax benefit in 2020);

◦the tax effect of nondeductible acquisition expenses ($2.8 tax expense in 2020);

•an adjustment to our transition tax liability pursuant to the Tax Act ($0.5 tax expense in 2019);

•an adjustment to our deferred tax liability as a result of revisions to our permanent reinvestment assertion on earnings of foreign subsidiaries driven by the Tax Act ($1.3 tax expense in 2019); and

•the tax effect of adjustments to income (loss) before income taxes.

The decrease in the current year adjusted effective tax rate was attributable to the tax benefit recognized from the revaluation of current and deferred tax balances, unrelated to the Milacron acquisition accounting, in connection with an enacted statutory tax rate reduction in a foreign jurisdiction in the first quarter of fiscal year 2020 as well as the impact of the increase in the reserve for unrecognized tax benefits in the prior year that did not recur in the current year.

Table of Contents

OPERATIONS REVIEW — PROCESS EQUIPMENT GROUP


	Three Months Ended June 30,											Nine Months Ended June 30,
	2020					2019				2020			2019
	Amount		% of Net Revenue	Amount		% of Net Revenue	Amount		% of Net Revenue	Amount		% of Net Revenue
Net revenue	$	281.3	100.0	$	315.3	100.0	$	899.0	100.0	$	924.2	100.0
Gross profit	104.1		37.0	107.9		34.2	318.1		35.4	324.4		35.1
Operating expenses	51.8		18.4	56.5		17.9	166.3		18.5	179.9		19.5
Amortization expense	7.3		2.6	8.6		2.7	22.0		2.4	25.0		2.7
Impairment charges	—		—	—		—	73.0		8.1	—		—

Three Months Ended June 30, 2020 Compared to Three Months Ended June 30, 2019

Net revenue decreased $34.0 (11%) primarily due to a decrease in large systems sales in plastics, largely driven by delays associated with the COVID-19 pandemic, and a decrease in demand for parts and service and other capital equipment, partially offset by favorable pricing. Foreign currency impact decreased net revenue by 1%.

Order backlog decreased $1.4 (0.2%) from $940.3 on June 30, 2019, to $938.9 on June 30, 2020. The decrease in backlog was primarily driven by foreign currency impact, which decreased order backlog by 1%. On a sequential basis, order backlog decreased $43.2 (4%) to $938.9 at June 30, 2020, down from $982.1 at March 31, 2020, with order softness across the segment due in part to the impact of COVID-19.

Gross profit decreased $3.8 (4%) primarily due to a decrease in large systems sales in plastics, largely driven by delays associated with the COVID-19 pandemic, a decline in demand for parts and service, and cost inflation, partially offset by pricing and productivity improvements, cost containment, and improved cost of quality. Foreign currency impact decreased gross profit by 1%. Gross profit margin improved 280 basis points to 37.0% in 2020, primarily due to pricing and productivity improvements and a supplier quality issue in the prior year that did not repeat in the current year, partially offset by cost inflation.

Operating expenses decreased $4.7 (8%) primarily due to a decrease in variable compensation, productivity improvements, and cost containment actions. Foreign currency impact decreased operating expenses by 1%. Operating expenses as a percentage of net revenue increased by 50 basis points to 18.4% in 2020.

Operating expenses included restructuring and restructuring-related charges ($1.8 in 2020 and $0.4 in 2019), business acquisition, disposition, and integration costs ($0.2 in 2020 and $0.1 in 2019), and costs associated with the COVID-19 pandemic of $0.6 in 2020. Excluding these items, adjusted operating expenses decreased $6.7 (12%) and adjusted operating expenses as a percentage of net revenue improved 30 basis points to 17.5% in 2020.

Amortization expense decreased $1.3 (15%), primarily due to amortization in the prior year that did not repeat on the acquired backlog of BM&M.

Nine Months Ended June 30, 2020 Compared to Nine Months Ended June 30, 2019

Net revenue decreased $25.2 (3%) primarily due to a decline in demand for screening and separating equipment (including equipment that processes proppants for hydraulic fracturing), other capital equipment, and parts and service, partially offset by increased demand for large systems in plastics and favorable pricing. Foreign currency impact decreased net revenue by 2%.

Gross profit decreased $6.3 (2%), primarily due to a decline in demand for screening and separating equipment (including equipment that processes proppants for hydraulic fracturing), cost inflation, and unfavorable mix due to an increased proportion of lower margin, large systems sales in plastics, partially offset by pricing and productivity improvements and an increase in volume of large systems sales in plastics. Foreign currency impact decreased gross profit by 1%. Gross profit margin improved

Table of Contents

30 basis points to 35.4% in 2020, primarily due to pricing and productivity improvements, partially offset by cost inflation and an increased proportion of lower margin, large systems sales in plastics.

Operating expenses decreased $13.6 (8%), primarily due to productivity initiatives, including savings from restructuring actions, a decrease in variable compensation, and cost containment actions. Foreign currency impact decreased operating expenses by 1%. Operating expenses as a percentage of net revenue improved by 100 basis points to 18.5% in 2020.

Operating expenses included restructuring and restructuring-related charges ($2.9 in 2020 and $0.5 in 2019), business acquisition, disposition, and integration costs ($0.8 in 2020 and $0.6 in 2019), and costs associated with the COVID-19 pandemic of $0.7 in 2020. Excluding these items, adjusted operating expenses decreased $16.9 (10%) and adjusted operating expenses as a percentage of net revenue improved 130 basis points to 18.0% in 2020.

Amortization expense decreased $3.0 (12%), primarily due to amortization in the prior year that did not repeat on the acquired backlog of BM&M.

Impairment charges were $73.0 due to goodwill and intangible asset impairments recorded in 2020. See Note 7 of Part I, Item 1 of this Form 10-Q for further information on the impairment charges.

OPERATIONS REVIEW — MILACRON


	Three Months Ended June 30, 2020					Nine Months Ended June 30, 2020
	Amount		% of Net Revenue	Amount		% of Net Revenue
Net revenue	$	186.3	100.0	$	518.6	100.0
Gross profit	52.0		27.9	116.9		22.5
Operating expenses	32.3		17.3	97.7		18.8
Amortization expense	9.1		4.9	33.2		6.4
Impairment charges	—		—	9.5		1.8

Since we acquired Milacron on November 21, 2019, we do not present comparative period results for variance analysis. Milacron’s results for the period since the acquisition date were significantly impacted by the non-recurring effects of the fair value adjustments to inventories and backlog required by acquisition accounting. These fair value adjustments are being recognized in the Consolidated Statements of Operations over the respective periods that inventory is expected to be consumed and backlog is expected to be realized as net revenue.

Three Months Ended June 30, 2020

Net revenue was $186.3 during the three months ended June 30, 2020. Net revenue was adversely impacted by the effects of the COVID-19 pandemic. On a sequential basis, order backlog decreased $2.7 (1%) to $184.7 at June 30, 2020, down from $187.4 at March 31, 2020. The decrease in backlog was primarily driven by a decrease in orders within our injection molding equipment and extrusion product lines, partially offset by an increase in orders within our hot runner product line.

Gross profit was $52.0 and gross profit margin was 27.9%. Milacron’s gross profit included inventory step-up charges of $3.6, restructuring and restructuring-related charges of $0.7, and costs associated with the COVID-19 pandemic of $0.6. Excluding these charges, adjusted gross profit margin was 30.5%.

Operating expenses were $32.3 and operating expense as a percentage of net revenue was 17.3%. Operating expenses included restructuring and restructuring-related charges of $0.9 and costs associated with the COVID-19 pandemic of $0.3. Excluding these charges, adjusted operating expenses as a percentage of net revenue was 16.6%.

Amortization expense was $9.1 related to the amortization on the intangible assets acquired in the Milacron acquisition.

Table of Contents

Nine Months Ended June 30, 2020

Net revenue was $518.6 since the acquisition date (November 21, 2019). Net revenue was adversely impacted by the effects of the COVID-19 pandemic.

Gross profit was $116.9 and gross profit margin was 22.5% since the acquisition date (November 21, 2019). Milacron’s gross profit included inventory step-up charges of $40.7, restructuring and restructuring-related charges of $0.5, and costs associated with the COVID-19 pandemic of $0.9. Excluding these charges, adjusted gross profit margin was 30.7%.

Operating expenses were $97.7 and operating expense as a percentage of net revenue was 18.8%. Operating expenses included business acquisition, disposition, and integration costs of $4.1 (including severance costs related to the integration) and restructuring and restructuring-related charges of $1.8. Excluding these charges, adjusted operating expenses as a percentage of net revenue was 17.6%.

Amortization expense was $33.2, including backlog amortization of $10.0.

Impairment charges were $9.5 due to intangible asset impairments. See Note 7 of Part I, Item 1 of this Form 10-Q for further information on the impairment charges.

OPERATIONS REVIEW — BATESVILLE


	Three Months Ended June 30,											Nine Months Ended June 30,
	2020					2019				2020			2019
	Amount		% of Net Revenue	Amount		% of Net Revenue	Amount		% of Net Revenue	Amount		% of Net Revenue
Net revenue	$	139.9	100.0	$	131.3	100.0	$	405.7	100.0	$	397.3	100.0
Gross profit	51.2		36.6	40.5		30.8	137.8		34.0	131.9		33.2
Operating expenses	16.8		12.0	19.4		14.8	52.7		13.0	57.8		14.5

Three Months Ended June 30, 2020 Compared to Three Months Ended June 30, 2019

Net revenue increased $8.6 (7%), primarily due to an increase in volume (8%), partially offset by a decrease in average selling price (1%). Higher volume was driven by an increase in burial casket sales primarily due to estimated higher deaths from the COVID-19 pandemic, partially offset by an estimated increased rate at which families opted for cremation.

 Gross profit increased $10.7 (26%) and gross profit margin improved 580 basis points to 36.6%. The increase in gross profit and gross profit margin was primarily due to higher volume, productivity initiatives, and deflation in commodities and fuel, partially offset by inflation in wages and benefits.

Gross profit included restructuring and restructuring-related charges of $0.3 in 2019 and costs associated with the COVID-19 pandemic of $0.2 in 2020. Excluding these charges, adjusted gross profit increased $10.5 (26%) and adjusted gross profit margin improved 560 basis points to 36.7%.

Operating expenses decreased $2.6 (13%) to $16.8 and operating expenses as a percentage of net revenue improved 280 basis points to 12.0%, primarily due to current year productivity initiatives, prior year restructuring actions, cost containment actions, and a decrease in restructuring and restructuring related expenses, partially offset by an increase in variable compensation.

Operating expenses included restructuring and restructuring-related charges ($0.1 in 2020 and $1.4 in 2019). Excluding these charges, adjusted operating expenses decreased $1.3 (7%) and adjusted operating expenses as a percentage of net revenue improved 180 basis points to 11.9% in 2020.

Nine Months Ended June 30, 2020 Compared to Nine Months Ended June 30, 2019

Net revenue increased $8.4 (2%), primarily due to an increase in volume (3%), partially offset by a decrease in average selling price (1%). Higher volume was driven by an increase in burial casket sales primarily due to estimated higher deaths from the COVID-19 pandemic, partially offset by an estimated increased rate at which families opted for cremation.

Table of Contents

 Gross profit increased $5.9 (5%) and gross profit margin improved 80 basis points to 34.0%. The increase in gross profit and gross profit margin was primarily due to higher volume, productivity initiatives, and deflation in commodities and fuel, partially offset by inflation in wages and benefits.

Gross profit included restructuring and restructuring-related charges of $0.5 in 2019, business acquisition, disposition, and integration costs of $0.2 in 2020, and costs associated with the COVID-19 pandemic of $0.2 in 2020. Excluding these charges, adjusted gross profit increased $5.8 (4%) and adjusted gross profit margin improved 80 basis points to 34.1%.

Operating expenses decreased $5.1 (9%) to $52.7 and operating expenses as a percentage of net revenue improved 150 basis points to 13.0%, primarily due to current year productivity initiatives, prior year restructuring actions, cost containment actions, and a decrease in restructuring and restructuring related expenses, partially offset by an increase in variable compensation.

Operating expenses included restructuring and restructuring-related charges ($0.6 in 2020 and $1.9 in 2019) and business acquisition, disposition, and integration costs of $0.2 in 2020. Excluding these charges, adjusted operating expenses decreased $4.0 (7%) and adjusted operating expenses as a percentage of net revenue improved 130 basis points to 12.8% in 2020.

REVIEW OF CORPORATE EXPENSES


	Three Months Ended June 30,											Nine Months Ended June 30,
	2020					2019				2020			2019
	Amount		% of Net Revenue	Amount		% of Net Revenue	Amount		% of Net Revenue	Amount		% of Net Revenue
Core operating expenses	$	12.3	2.0	$	11.1	2.5	$	33.4	1.8	$	33.0	2.5
Business acquisition, disposition, and integration costs	5.2		0.9	3.7		0.8	61.7		3.4	4.4		0.3
Restructuring and restructuring-related charges	—		—	0.1		—	—		—	0.1		—
COVID-19 pandemic-related costs	0.1		—	—		—	0.1		—	—		—
Operating expenses	$	17.6	2.9	$	14.9	3.3	$	95.2	5.2	$	37.5	2.8

Corporate operating expenses include the cost of providing management and administrative services to each reportable operating segment. These services include treasury management, human resources, legal, business development, and other public company support functions such as information technology, internal audit, investor relations, financial reporting, and tax compliance. Corporate operating expenses also include costs related to business acquisition, disposition, and integration, which we incur as a result of our strategy to grow through selective acquisitions. Core operating expenses primarily represent corporate operating expenses excluding costs related to business acquisition, disposition, and integration costs.

Business acquisition, disposition, and integration costs include legal, tax, accounting, and other advisory fees and due diligence costs associated with investigating opportunities (including acquisitions and dispositions) and integrating completed acquisitions (including severance).

Three Months Ended June 30, 2020 Compared to Three Months Ended June 30, 2019

Operating expenses increased $2.7 (18%), primarily due to an increase in business acquisition, disposition, and integration costs as a result of the acquisition of Milacron, and the additional operating expenses from Milacron, partially offset by cost containment actions and a decrease in variable compensation. These expenses as a percentage of net revenue were 2.9%, an improvement of 40 basis points from the prior year, primarily driven by the addition of Milacron revenue and the synergies realized in relation to combining two corporate centers and eliminating duplicative public company-related costs.

Core operating expenses increased $1.2 (11%), primarily driven by the additional operating expenses from Milacron, partially offset by cost containment actions and a decrease in variable compensation. These expenses as a percentage of net revenue were 2.0%, an improvement of 50 basis points from the prior year, primarily driven by the addition of Milacron revenue and the synergies realized in relation to combining two corporate centers and eliminating duplicative public company-related costs.

Table of Contents

Nine Months Ended June 30, 2020 Compared to Nine Months Ended June 30, 2019

Operating expenses increased $57.7 (154%), primarily due to an increase in business acquisition, disposition, and integration costs as a result of the acquisition of Milacron and the divestiture of Cimcool and the additional operating expenses from Milacron, partially offset by cost containment actions and a decrease in variable compensation. These expenses as a percentage of net revenue were 5.2%, an increase of 240 basis points from the prior year.

Core operating expenses increased $0.4 (1%), primarily driven by the additional operating expenses from Milacron, partially offset by cost containment actions and a decrease in variable compensation. These expenses as a percentage of net revenue were 1.8%, an improvement of 70 basis points from the prior year, primarily driven by the addition of Milacron revenue and the synergies realized in relation to combining two corporate centers and eliminating duplicative public company-related costs.

NON-GAAP OPERATING PERFORMANCE MEASURES

The following is a reconciliation from the most directly comparable GAAP operating performance measure to our non-GAAP adjusted EBITDA.


	Three Months Ended June 30,						Nine Months Ended June 30,
	2020		2019		2020		2019
Consolidated net income (loss)	$	25.0	$	31.7	$	(48.0)	$	100.2
Interest income	(0.6)		(0.3)		(2.5)		(0.7)
Interest expense	19.7		5.2		55.3		16.1
Income tax expense	28.3		11.6		17.7		39.9
Depreciation and amortization	33.9		15.1		98.4		44.3
EBITDA	106.3		63.3		120.9		199.8
Impairment charges ⁽¹⁾	—		—		82.5		—
Business acquisition, disposition, and integration costs ⁽²⁾	5.5		3.8		67.3		4.9
Restructuring and restructuring-related charges ⁽³⁾	3.6		2.4		6.7		3.6
Inventory step-up ⁽⁴⁾	3.6		—		40.7		0.2
Net loss on divestiture ⁽⁵⁾	—		—		3.0		—
Other ⁽⁶⁾	2.0		—		2.4		—
Adjusted EBITDA	$	121.0	$	69.5	$	323.5	$	208.5

⁽¹⁾Hillenbrand recorded impairment charges to goodwill and certain identifiable intangible assets within both the Process Equipment Group and Milacron reportable segments during the nine months ended June 30, 2020. See Note 7 of Part I, Item 1 of this Form 10-Q for more information.

⁽²⁾Business acquisition, disposition, and integration costs during the three and nine months ended June 30, 2020 primarily included $5.0 and $62.7, respectively, of expenses for the settlement of outstanding Milacron share-based equity awards, professional fees, and severance and employee-related costs in connection with the acquisition and integration of Milacron. The remaining costs incurred during the three and nine months ended June 30, 2020 were primarily related to professional fees and other transaction costs in connection with the divestiture of Cimcool. Business acquisition, disposition, and integration costs during the three and nine months ended June 30, 2019 primarily included professional fees.

⁽³⁾Restructuring and restructuring-related charges primarily included severance costs, unrelated to the acquisition and integration of Milacron, during the three and nine months ended June 30, 2020 and 2019.

⁽⁴⁾Represents the non-cash charges related to the fair value adjustment of inventories acquired in connection with the acquisitions of Milacron and BM&M during 2020 and 2019, respectively. See Note 4 of Part I, Item 1 of this Form 10-Q for more information on the acquisitions of Milacron and BM&M.

⁽⁵⁾Hillenbrand recorded a pre-tax net loss on the divestiture of Cimcool during the nine months ended June 30, 2020. See Note 4 of Part I, Item 1 of this Form 10-Q for more information on the divestiture of Cimcool.

⁽⁶⁾Other primarily included incremental expenses directly attributable to the COVID-19 pandemic, such as costs for sanitary supplies, bad debt expense, and transportation costs, during the three and nine months ended June 30, 2020.

Table of Contents

Three Months Ended June 30, 2020 Compared to Three Months Ended June 30, 2019

Consolidated net income (loss) decreased $6.7 (21%) for the three months ended June 30, 2020, compared to the same period in 2019. The decrease was primarily driven by inventory step-up charges and additional amortization on intangibles in relation to the acquisition of Milacron, an increase in interest expense, an increase in business acquisition, disposition, and integration costs, primarily in relation to the acquisition of Milacron, inflation in wages and benefits, and a decline in demand for parts and service, large system sales in plastics and other capital equipment at the Process Equipment Group. This decrease in consolidated net income (loss) was partially offset by pricing and productivity improvements, increased volume at Batesville, and cost containment actions. Foreign currency impact decreased consolidated net income (loss) by $0.5.

Consolidated adjusted EBITDA increased $51.5 (74%) for the three months ended June 30, 2020, compared to the same period in 2019. The increase was primarily due to the acquisition of Milacron, pricing and productivity improvements, increased volume at Batesville, and cost containment actions. This increase in consolidated adjusted EBITDA was partially offset by inflation in wages and benefits and a decline in demand for parts and service, large system sales in plastics and other capital equipment at the Process Equipment Group. Foreign currency impact decreased adjusted EBITDA by $0.8.

Nine Months Ended June 30, 2020 Compared to Nine Months Ended June 30, 2019

Consolidated net income (loss) decreased $148.2 (148%) for the nine months ended June 30, 2020, compared to the same period in 2019. The decrease was primarily driven by impairment charges, inventory step-up charges and additional amortization on intangibles in relation to the acquisition of Milacron, an increase in business acquisition, disposition, and integration costs, primarily in relation to the acquisition of Milacron, an increase in interest expense, inflation in wages and benefits, and a decline in demand for screening and separating equipment (including equipment that processes proppants for hydraulic fracturing) and other capital equipment at the Process Equipment Group. This decrease in consolidated net income (loss) was partially offset by a decrease in income tax expense, pricing and productivity improvements, higher volume at Batesville, cost containment actions, a decrease in variable compensation, and increased demand for large systems in plastics at the Process Equipment Group. Foreign currency impact decreased consolidated net income (loss) by $1.2.

Consolidated adjusted EBITDA increased $115.0 (55%) for the nine months ended June 30, 2020, compared to the same period in 2019. The increase was primarily due to the acquisition of Milacron, pricing and productivity improvements, higher volume at Batesville, cost containment actions, a decrease in variable compensation, and increased demand for large systems in plastics at the Process Equipment Group. This increase in consolidated adjusted EBITDA was partially offset by inflation in wages and benefits and a decline in demand for screening and separating equipment (including equipment that processes proppants for hydraulic fracturing) and other capital equipment at the Process Equipment Group. Foreign currency impact decreased adjusted EBITDA by $2.3.

LIQUIDITY AND CAPITAL RESOURCES

In this section, we discuss our ability to access cash to meet business needs. We discuss how we see cash flow being affected for the next twelve months and how we intend to use it. We describe actual results in generating and using cash by comparing the first nine months of 2020 to the same period last year. Finally, we identify other significant matters that could affect liquidity on an ongoing basis.

Ability to Access Cash

Our debt financing has historically included revolving credit facilities, term loans, and long-term notes as part of our overall financing strategy. We regularly review and adjust the mix of fixed-rate and variable-rate debt within our capital structure in order to achieve a target range based on our financing strategy.

We have taken proactive measures to maintain financial flexibility within the landscape of the COVID-19 pandemic. We believe the Company ended the quarter with and continues to have sufficient liquidity to operate in the current business environment. Hillenbrand increased cash holdings over the past two quarters (from December 31, 2019 to June 30, 2020) by $120.7, primarily with cash proceeds from the issuance of $400.0 in senior unsecured notes in June 2020 and net cash proceeds of $222.4 from the sale of the Cimcool business in March 2020, partially offset by repayments made on the Revolver. As of June 30, 2020, Hillenbrand was in full compliance with all covenants under its financing agreements. We continue to evaluate additional measures to maintain financial flexibility and general working capital requirements as a result of the COVID-19 pandemic. As the impact of the COVID-19 pandemic on the economy and our operations has been changing frequently and evolving rapidly, we will continue to closely monitor our liquidity and capital resources through the disruption caused by COVID-19 and continue to assess cuts to discretionary spending and other variable costs.

Table of Contents

As of June 30, 2020, we had $891.9 of maximum borrowing capacity under the Revolver, of which $642.4 was immediately available based on our most restrictive covenant. The available borrowing capacity reflects a reduction of $8.1 for outstanding letters of credit issued under the Revolver. The Company may request an increase of up to $450.0 in the total borrowing capacity under the Revolver, subject to approval of the lenders.

In the normal course of business, operating companies within the Process Equipment Group and Milacron reportable segments provide to certain customers bank guarantees and other credit arrangements in support of performance, warranty, advance payment, and other contractual obligations. This form of trade finance is customary in the industry and, as a result, we maintain adequate capacity to provide the guarantees. As of June 30, 2020, we had guarantee arrangements totaling $383.7, under which $267.4 was used for guarantees. These arrangements include the L/G Facility Agreement under which unsecured letters of credit, bank guarantees, or other surety bonds may be issued. The Company may request an increase to the total capacity under the L/G Facility Agreement by an additional €70.0, subject to approval of the lenders. In January 2020, the L/G Facility Agreement was amended to expand the size of the existing €150.0 facility by an additional €25.0.

We have significant operations outside the U.S. We continue to assert that the basis differences in the majority of our foreign subsidiaries continue to be permanently reinvested outside of the U.S. We have recorded tax liabilities associated with distribution taxes on expected distributions of available cash and current earnings. The Company has made, and intends to continue to make, substantial investments in our businesses in foreign jurisdictions to support the ongoing development and growth of our international operations. As of June 30, 2020, we had a transition tax liability of $19.7 pursuant to the Tax Act. The cash at our foreign subsidiaries totaled $196.2 at June 30, 2020. We continue to actively evaluate our global capital deployment and cash needs.

12-month Outlook

As discussed in the COVID-19 Impact section above, the Company has taken actions aimed to safeguard its capital position in the current COVID-19 environment. We believe the Company has sufficient liquidity to operate in the current business environment. The challenges posed by COVID-19 on our businesses have evolved rapidly over the past two quarters and are likely to evolve further. Consequently, we will continue to evaluate our financial position in light of future developments, particularly those relating to COVID-19, and we plan to take necessary steps to manage through such developments.

Events resulting from the effects of the ongoing COVID-19 pandemic may negatively impact our ability to comply with the covenants under the Revolver, which could lead us to seek an amendment or waivers from our lenders, limit access to or require accelerated repayment of our existing credit facilities, or require us to pursue alternative financing. We have no assurance that any such alternative financing, if required, could be obtained at terms acceptable to us, or at all, including as a result of the effects of COVID-19 on the financial markets at such time.

$400.0 senior unsecured notes

On June 16, 2020, we issued $400.0 of senior unsecured notes due June 2025 (the “2020 Notes”). The 2020 Notes were issued at par value and bear interest at a fixed rate of 5.75% per year, payable semi-annually in arrears beginning December 2020. Deferred financing costs associated with the 2020 Notes of $5.5 are being amortized to interest expense on a straight-line basis over the term of the 2020 Notes.

Acquisitions and divestitures

As discussed in Note 4 of Part I, Item 1 of this Form 10-Q, on November 21, 2019, we completed the acquisition of Milacron for a total purchase price of approximately $2.0 billion through a merger of our wholly-owned subsidiary with and into Milacron, resulting in ownership of 100% of Milacron common stock that was issued and outstanding after the merger. Hillenbrand used approximately $1.75 billion of borrowings from notes, term loans, and the Revolver to pay the aggregate cash portion of the merger consideration, to pay off Milacron’s existing debt, and to pay fees and expenses related to the transaction. These borrowings were comprised of the following:

•$374.4 (net of discount) was raised in connection with issuing publicly traded notes in September 2019;

•$650.0 of additional borrowings under the Revolver. With respect to the Revolver, Hillenbrand has made repayments since the closing date of the acquisition of Milacron, resulting in no outstanding balance as of June 30, 2020; and

•Two term loan commitments totaling $725.0 in principal.

See Note 8 included in Part 1, Item 1 of this Form 10-Q for further details on the financing for the Milacron acquisition.

Table of Contents

We completed the divestiture of Cimcool on March 30, 2020, resulting in cash proceeds of $222.4, net of cash divested, at closing. We primarily used the cash proceeds to pay down debt.

From a strategic perspective and following the most recent review of the Company’s portfolio, we have made the decision to exit the TerraSource and the Flow Control businesses, pending market conditions. We have a process in place to review the Company’s portfolio on a regular basis, and following the transformational acquisition of Milacron and with the integration under way, we believe these businesses are now subscale within our portfolio.

The Company’s stated goal was to return net leverage (defined as debt, net of cash, to adjusted EBITDA) to below 2.75x within twelve months of the date the Milacron acquisition was completed, November 21, 2019. The Company remains committed to de-leveraging and intends to prioritize paying down its debt over the next twelve months; however, the effects of COVID-19 are expected to continue to impact our cash flow and our ability to de-leverage at the pace we have previously anticipated. The timeline has shifted and will depend on the severity and duration of the current macroeconomic uncertainty created by the pandemic.

Amendments to current financing agreements

On January 10, 2020, we amended the Credit Agreement (along with other of our financing agreements) to, among other things, (i) increase the maximum permitted leverage ratio; and (ii) add additional pricing levels to compensate for the increase in permitted leverage ratios.

On May 19, 2020, we further amended the Credit Agreement (along with other of our financing agreements) to, among other things, (i) increase the maximum permitted leverage ratio for current and future quarters to; (ii) increase the margin paid on various rates defined in the Credit Agreement at certain pricing levels; (iii) add additional pricing levels to compensate for the increase in permitted leverage ratios; (iv) increase the interest rate floor for various rates defined in the Credit Agreement; (v) add as a condition to each borrowing under the Revolver that the amount of cash or cash equivalents on our Consolidated Balance Sheet not exceed $350.0, subject to certain exceptions; and (vi) impose certain restrictions on our ability to make restricted payments, including limitations on share repurchases and the payment of dividends, and grant liens on assets until January 1, 2022.

See Note 8 included in Part 1, Item 1 of this Form 10-Q for further details on these amendments.

Credit ratings update

The coupon rate on the $375.0 senior unsecured notes is impacted by public bond ratings from Moody’s and S&P Global. Downgrades from either rating agency will increase the coupon rate by 0.25% per downgrade level if the ratings are below investment grade. During the three months ended June 30, 2020, Moody’s and S&P Global each downgraded the Company’s senior unsecured credit rating by one level. As such, the original coupon rate of 4.5% on the $375.0 senior unsecured notes will increase to 5.0%, effective September 15, 2020.

Other activities

Upon maturity in July 2020, we refinanced the $150.0 senior unsecured notes issued in July 2010 on a long-term basis, as they were repaid with available borrowing capacity from the Revolver. There were no outstanding borrowings under the Revolver as of June 30, 2020, primarily due to repayments made with proceeds from the 2020 Notes issued in June 2020. As such, the $150.0 senior unsecured notes were classified as long-term debt within the Consolidated Balance Sheet as of June 30, 2020.

The Tax Act requires the Company to pay a transition tax on unremitted earnings of its foreign subsidiaries, resulting in an estimated liability of $19.7 recorded as of June 30, 2020. The transition tax liability under the Tax Act will be paid over the next five years. In addition, we expect the lower corporate tax rate of 21% to benefit our cash flow in current and future periods.

In December 2018, our Board of Directors authorized a new share repurchase program of up to $200.0. The Company has temporarily suspended share repurchases in the near term as a result of the priority given to paying down long-term debt following the acquisition of Milacron and conserving cash in light of the impact of COVID-19.

Our anticipated contribution to our defined benefit pension plans in 2020 is $9.3, of which $7.5 was made during the nine months ended June 30, 2020. We will continue to monitor plan funding levels, performance of the assets within the plans, and

Table of Contents

overall economic activity, and we may make additional discretionary funding decisions based on the net impact of the above factors.

We expect that the aggregate amount of our quarterly cash dividends will increase in the future compared to those we paid in 2019 as result of the additional common stock issued in connection with the acquisition of Milacron. We currently expect to pay approximately $16.0 each quarter based on our outstanding common stock at June 30, 2020. We increased our quarterly dividend in 2020 to $0.2125 per common share from $0.2100 per common share paid in 2019. As of the date of this filing, the Company is committed to paying our dividend, and our policy remains unchanged. As with all discretionary cash outlays, if the current economic challenges become significantly more pronounced or extended over a longer-than-expected period, the Company would evaluate all opportunities to preserve capital, including a dividend adjustment. We cannot predict whether, and to what extent, such an adjustment would be made given the various potential factors that could exist at such time.

We believe existing cash, cash flows from operations, borrowings under existing arrangements, and the issuance of debt will be sufficient to fund our operating activities and cash commitments for investing and financing activities. Based on these factors, we believe our current liquidity position is sufficient and will continue to meet all of our financial commitments in the current business environment. However, as mentioned above, management is continuing to evaluate the Company’s liquidity position, communicating with and monitoring the actions of our customers and suppliers, and reviewing our near-term financial performance as we manage the Company through the uncertainty related to COVID-19.

Cash Flows


	Nine Months Ended June 30,
	2020		2019
Cash flows provided by (used in)
Operating activities	$	120.1	$	109.6
Investing activities	(1,286.8)		(38.4)
Financing activities	1,031.1		(62.5)
Effect of exchange rates on cash and cash equivalents	1.1		(0.2)
Net cash flows	$	(134.5)	$	8.5

Operating Activities

Operating activities provided $120.1 of cash during the first nine months of 2020, and provided $109.6 of cash during the first nine months of 2019, a $10.5 (10%) increase. The increase in operating cash flow was primarily due to reduced working capital requirements, the additional cash flow provided by Milacron in 2020, cost containment actions taken during 2020, and a decrease in income taxes paid, partially offset by an increase in payments for business acquisition, disposition, and integration costs in relation to the acquisition of Milacron and divestiture of Cimcool as well as higher interest paid.

Working capital requirements for the Process Equipment Group and Milacron reportable segments may continue to fluctuate in the future due primarily to the type of product and geography of customer projects in process at any point in time. Working capital needs are lower when advance payments from customers are more heavily weighted toward the beginning of the project. Conversely, working capital needs are higher when a larger portion of the cash is to be received in later stages of manufacturing.

Investing Activities

The $1,248.4 increase in cash used in investing activities in the first nine months of 2020 was primarily due to a cash outflow of $1,503.1 for the acquisition of Milacron in the current period, compared to $25.9 for the acquisition of BM&M in the prior year period. Additionally, capital expenditures increased by $7.7 compared to the prior year period, primarily related to the acquisition of Milacron in the current period. These cash outflows were partially offset by inflows of $222.4 due to proceeds from the divestiture of Cimcool and $13.1 due to proceeds received from the sale of a Milacron manufacturing facility during the current period. See Note 4 included in Part 1, Item 1 of this Form 10-Q for further details on these acquisitions and divestitures.

Table of Contents

Financing Activities

Cash provided by financing activities was largely impacted by net borrowing activity. Our general practice is to use available cash to pay down debt unless it is needed for an acquisition. Cash provided by financing activities during the first nine months of 2020 was $1,031.1, including $1,096.9 of proceeds, net of debt repayments. Cash provided by financing activities in the first nine months of 2019 was $62.5, including $20.4 of debt repayments, net of proceeds. The increase in cash provided by financing activities was primarily due to the issuance of two term loan commitments totaling $725.0 for financing the Milacron acquisition, the issuance of the 2020 Notes for $400.0, and a decrease in net repayments on the Revolver of $19.3 compared to the prior year period.

We returned $47.6 to shareholders during the first nine months of 2020 in the form of quarterly dividends. We increased our quarterly dividend in 2020 to $0.2125 per common share from $0.2100 per common share paid during 2019.

Off-Balance Sheet Arrangements

As part of its normal course of business, Hillenbrand is a party to various financial guarantees and other commitments. These arrangements involve elements of performance and credit risk that are not included in the Consolidated Balance Sheets. The possibility that Hillenbrand would have to make actual cash expenditures in connection with these obligations is largely dependent on the performance of the guaranteed party, or the occurrence of future events that Hillenbrand is unable to predict. We have no off-balance sheet financing agreements or guarantees at June 30, 2020, that we believe are reasonably likely to have a current or future effect on our financial condition, results of operations, or cash flows.

Contractual Obligations and Contingent Liabilities and Commitments

For a full summary of our future obligations, refer to Management’s Discussion and Analysis of Financial Condition and Results of Operations, Liquidity and Capital Resources, in our Annual Report on Form 10-K for the year ended September 30, 2019 (the “2019 Form 10-K”). This information is intended to give you an understanding of the significance of cash outlays that are fixed beyond the normal accounts payable we have already incurred and have recorded in the Consolidated Financial Statements.

The following table provides updated amounts for our contractual obligations that have changed significantly since the filing of our 2019 Form 10-K. The changes resulted from debt obligations and operating lease liabilities assumed in connection with the acquisition of Milacron.


	Payment Obligations by Year
As of June 30, 2020	Total		Remainder of 2020		2021 - 2022		2023 - 2024		Thereafter
$500.0 term loan	$	481.3	$	6.3	$	62.5	$	87.5	$	325.0
$225.0 term loan	216.6		2.8		28.2		185.6		—

$400.0 senior unsecured notes	400.0		—		—		—		400.0
Interest on financing agreements ⁽¹⁾	304.6		16.4		125.4		110.9		51.9
Operating lease payments	173.4		13.4		62.5		39.3		58.2

⁽¹⁾Cash obligations for interest requirements relate to our fixed-rate debt obligations at the contractual rates and our variable-rate debt obligations at the current rates as of June 30, 2020.

Summarized Financial Information for Guarantors and the Issuer of Guaranteed Securities

Summarized financial information of Hillenbrand (the “Parent”) and our subsidiaries that are guarantors of our senior unsecured notes (the “Guarantor Subsidiaries”) is shown below on a combined basis as the “Obligor Group.” The Company’s senior unsecured notes are guaranteed by certain of our wholly-owned domestic subsidiaries and rank equally in right of payment with all of our existing and financial information of the Obligor Group, all intercompany balances and transactions between the Parent and Guarantor Subsidiaries have been eliminated and all information excludes subsidiaries that are not issuers or guarantors of our senior unsecured notes, including earnings from and investments in these entities.

Table of Contents


	June 30, 2020		September 30, 2019
Combined Balance Sheets Information:
Current assets ⁽¹⁾	$	1,450.6	$	1,681.5
Non-current assets	4,506.7		2,634.4
Current liabilities ⁽¹⁾	1,677.2		1,343.0
Non-current liabilities	1,766.0		710.8

	Nine Months Ended June 30, 2020		Year Ended September 30, 2019
Combined Statements of Operations Information:
Revenue ⁽²⁾	$	630.2	$	893.7
Gross profit	283.8		400.0
Net income (loss) attributable to Obligors	(11.7)		243.6

⁽¹⁾ Current liabilities include intercompany payables to non-guarantors of $135.7 as of June 30, 2020 and Current assets included intercompany receivables with non-guarantors $5.3 as of September 30, 2019.

⁽²⁾ Revenue includes intercompany sales with non-guarantors of $39.7 as of June 30, 2020 and $53.0 as of September 30, 2019.

Recently Adopted and Issued Accounting Standards

For a summary of recently issued and adopted accounting standards applicable to us, see Item 1, Note 2 of Part I of this Form 10-Q.

Factors that could result in additional impairment

As discussed in Note 7 of Part I of this Form 10-Q, testing for impairment of goodwill and indefinite lived assets must be performed annually, or on an interim basis upon the occurrence of triggering events or substantive changes in circumstances that indicate that the fair value of the asset or reporting unit may have decreased below the carrying value. As a result of our revised forecasts driven by the impact of the COVID-19 pandemic on all reporting units within the Milacron reportable segment, we performed an interim impairment review for these reporting units during the three months ended March 31, 2020 and determined that no impairment of goodwill occurred as a result of this triggering event. The estimated fair value, as calculated, for all four reporting units within the Milacron reportable segment ranged from approximately 3% to 16% greater than their carrying value as of March 31, 2020. Under the relief-from-royalty fair value method, we concluded that the carrying value of certain trade names and technology associated with these reporting units exceeded their fair value. As a result, impairment charges of $9.5 were recorded for these intangible assets during the three months ended March 31, 2020. The pre-impairment balance for these intangible assets was $125.0. A 10% further reduction in the fair value of these intangible assets, caused by further declines in forecasted revenues and changes in the discount rate selected by management, would indicate a potential additional impairment of approximately $12.0. During the three months ended June 30, 2020, there were no material changes to the Company’s previous forecasts or significant changes in macroeconomic conditions that triggered an interim impairment review.

The valuation used to test goodwill and identifiable intangible assets for impairment is dependent upon a number of significant estimates and assumptions, including macroeconomic conditions, growth rates, competitive activities, cost containment, margin expansion, and our business plans. We believe these estimates and assumptions are reasonable. However, future changes in the judgments, assumptions and estimates that are used in our impairment testing for goodwill and identifiable intangible assets, including discount and tax rates or future cash flow projections, could result in significantly different estimates of the fair values. As a result of these factors and the limited cushion (or headroom as commonly referred) due to the recent acquisition of Milacron, goodwill and identifiable intangible assets for the reporting units within the Milacron reportable segment are more susceptible to impairment risk.

Table of Contents

likely to be expected by a market participant, is based upon industry required rates of return, including consideration of both debt and equity components of the capital structure. The discount rates may be impacted by adverse changes in the macroeconomic environment, specifically the COVID-19 pandemic, volatility in the equity and debt markets, or other factors.

While management can implement and has implemented certain strategies to address these events, changes in operating plans or other adverse changes in the future could reduce the underlying cash flows used to estimate reporting unit fair values and could result in a further decline in fair value that would trigger a future material impairment charge of the reporting units’ goodwill and identifiable intangible asset balances.

Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

(financial amounts in millions)

A full discussion of quantitative and qualitative disclosures about market risk may be found in Item 7A of our 2019 Form 10-K. The following discussion provides information on significant changes to our market risks that we think could have a significant impact to our bottom line or the financial strength of the Company. These changes resulted from an increase to our variable-rate debt obligations and additional foreign currency exposures as a result of the acquisition of Milacron. As discussed elsewhere in this Form 10-Q, the recent COVID-19 pandemic is negatively impacting our business and results of operations. As we cannot predict the duration and scope of the COVID-19 pandemic, the negative financial impact and economic risk to our results cannot be reasonably estimated, but could be material.

Interest rate risk

As of September 30, 2019, we had no outstanding variable-rate debt obligations. As of June 30, 2020, our variable-rate debt obligations were $696.1, which included borrowings under our two term loan commitments that were issued in connection with the acquisition of Milacron. We are subject to interest rate risk associated with such borrowings, which bear a variable rate of interest that is based upon, at the Company’s option, the LIBO Rate or the Alternate Base Rate (each as defined in the Credit Agreement) plus a margin based on the Company’s leverage ratio. The interest we pay on such borrowings is dependent on interest rate conditions and the timing of our financing needs. If we assumed the borrowings under our variable-rate debt obligations remained at $696.1 for 12 months, a one percentage point change in the related interest rates would decrease or increase annual interest expense by approximately $7.0.

In July 2017, the Financial Conduct Authority (the authority that regulates LIBOR, the London Inter-bank Offered Rate) announced that it intends to stop compelling banks to submit rates for the calculation of LIBOR after 2021. The Alternative Reference Rates Committee (“ARRC”) has proposed that the Secured Overnight Financing Rate (“SOFR”) is the rate that represents best practice as the alternative to USD-LIBOR for use in derivatives and other financial contracts that are currently indexed to USD-LIBOR. ARRC has proposed a paced market transition plan to SOFR from USD-LIBOR and organizations are currently working on industry-wide and company-specific transition plans as it relates to derivatives and cash markets exposed to USD-LIBOR. The Company has material contracts that are indexed to USD-LIBOR and is monitoring this activity and evaluating the related risks.

Foreign currency risk

We are subject to variability in foreign currency exchange rates in our international operations. We have a hedging program in place which is designed to limit the exposure to this variability through the use of natural hedges and also by entering into currency exchange agreements. Due to Milacron’s significant international operations, we have additional exposures to the variability in certain foreign currencies. Under our hedging program, we believe we have taken steps to effectively hedge any significant additional exposures resulting from the Milacron acquisition. As such, there is no significant impact to pre-tax earnings during the current period as a result of exchange rates on transactions denominated in non-functional currencies.

Item 4. CONTROLS AND PROCEDURES

(financial amounts in millions)

Our management, with the participation of our President and Chief Executive Officer and our Senior Vice President and Chief Financial Officer (the “Certifying Officers”), evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based upon that evaluation, the Certifying Officers concluded that our disclosure controls and procedures as of the end of the period covered by this report are effective.

Table of Contents

In the ordinary course of business, we review our system of internal control over financial reporting and make changes to our systems and processes to improve such controls and increase efficiency, while ensuring that we maintain an effective internal control environment. Changes may include such activities as implementing new, more efficient systems, automating manual processes, and updating existing systems.

On November 21, 2019, we completed the acquisition of Milacron, which includes its existing information systems and internal controls over financial reporting. In conducting our evaluation of the effectiveness of our internal control over financial reporting for our fiscal year ended September 30, 2020, we plan to exclude Milacron from our evaluation as permitted under existing SEC Staff interpretive guidance for newly acquired businesses. We are currently in the process of evaluating and integrating Milacron’s historical internal controls over financial reporting with ours. The integration may lead to changes in future fiscal periods but we do not expect these changes to materially affect our internal controls over financial reporting. We expect to complete this integration in fiscal 2021. For the nine months ended June 30, 2020, Milacron accounted for $518.6 of our total net revenue, and as of June 30, 2020, had total assets of $1,988.0 (inclusive of acquired goodwill and identifiable intangible assets of $1,271.2).

During the nine months ended June 30, 2020 and through the date of this filing, we have not experienced any material impact to our internal controls over financial reporting despite the fact that many of our non-production employees are working remotely due to the COVID-19 pandemic. We are continually monitoring and assessing the COVID-19 situation on our internal controls to minimize the impact to their design and operating effectiveness.

Other than as noted above, there were no changes in internal control over financial reporting identified in the evaluation for the quarter ended June 30, 2020, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act.

PART II — OTHER INFORMATION

Item 1. LEGAL PROCEEDINGS

Information pertaining to legal proceedings can be found in Note 15 to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

Item 1A. RISK FACTORS

(financial amounts in millions)

For information regarding the risks we face, see the discussion under Item 1A. Risk Factors in our Annual Report on Form 10-K for the year ended September 30, 2019, and the additional risk factors below. The following descriptions of risk factors include any additions and material changes to, and supersede the corresponding descriptions of, the risk factors associated with our business as previously disclosed in our Annual Report on Form 10-K for the year ended September 30, 2019. As described herein, the COVID-19 pandemic may adversely affect our business and financial results and may also have the effect of heightening many of the other risks described in this section and in the “Risk Factors” section of our Annual Report on Form 10-K for the year ended September 30, 2019.

1. The COVID-19 pandemic could have a material adverse effect on our business and results of operations, the nature and extent of which are highly uncertain and unpredictable.

The COVID-19 pandemic, and the various government, industry and consumer actions related thereto, are having and are likely to continue to have negative impacts on our business, and have created or could create or intensify adverse conditions described in our other risk factors. These impacts and conditions include, but are not limited to, potential significant volatility or decreases in demand for our products, changes in customer behavior and preferences, disruptions in or closures of our manufacturing operations or those of our customers and suppliers, disruptions within our supply chain, limitations on our employees’ ability to work and travel, potential increased vulnerability to cybersecurity incidents, including breaches of information systems security due to widespread remote working arrangements, potential financial difficulties of customers and suppliers, significant changes in economic or political conditions, including rapidly changing government orders and regulations and our efforts to comply with them, and related financial and commodity volatility, including volatility in raw material and other input costs (including but not limited to oil prices), any of which could last for extended periods. Disruption caused by the COVID-19 pandemic and the Company’s response to the COVID-19 pandemic could also increase the Company’s exposure to claims from customers, suppliers, financial institutions, regulators, payment card associations,

Table of Contents

employees and others, any of which could have a material adverse effect on the Company’s financial condition and results of operations. Furthermore, the pandemic has impacted and may further impact the broader economies of affected countries, including negatively impacting economic growth, the proper functioning of financial and capital markets, foreign currency exchange rates, and interest rates. For example, the continued spread of COVID-19 has led to disruption and volatility in the global capital markets, which increases the cost of capital and adversely impacts access to capital.

Despite our efforts to manage through the current circumstances, the degree to which COVID-19 and related actions ultimately impact our business, financial position, results of operations, and cash flows may depend on certain factors beyond our control, including the duration, spread, and severity of the pandemic, the actions taken to contain COVID-19 and mitigate its public health effects, the impact on the U.S. and global economies and demand for our products, and how quickly and to what extent normal economic and operating conditions resume or become impacted by long-lasting changes. The extent to which COVID-19 may impact our business, while likely to continue to be significant, cannot be predicted with certainty.

2. We may be unable to successfully integrate the businesses of Hillenbrand and Milacron and realize the anticipated benefits of the merger.

On November 21, 2019, we completed the acquisition of Milacron. The success of the merger will depend, in part, on the Company’s ability to successfully combine and integrate the businesses of Hillenbrand and Milacron, which previously operated as independent public companies, and realize the anticipated benefits, including synergies, cost savings, innovation opportunities, and operational efficiencies, in a manner that does not materially disrupt existing customer, supplier, and employee relations nor result in decreased revenues due to losses of, or decreases in orders by, customers. If the Company is unable to achieve these objectives within the anticipated time frame, or at all, the anticipated benefits may not be realized fully or at all, or may take longer to realize than expected, and the value of the Company’s common stock may decline.

The integration of the two companies may result in material challenges, including, without limitation:

•the diversion of management’s attention from ongoing business concerns and performance shortfalls at one or both of the companies as a result of the devotion of management’s attention to the merger or integration;

•managing a larger combined business;

•maintaining employee morale and retaining key management and other employees;

•retaining existing business and operational relationships, including customers, suppliers and employees and other counterparties, as may be impacted by contracts containing consent and/or other provisions that may be triggered by the merger, and attracting new business and operational relationships;

•the possibility of faulty assumptions underlying expectations regarding the integration process;

•consolidating corporate and administrative infrastructures and eliminating duplicative operations;

•coordinating geographically separate organizations; and

•unanticipated issues in integrating information technology, communications and other systems.

Some of these factors are outside of the Company’s control, including certain impacts of the COVID-19 pandemic discussed elsewhere in our risk factors, and any one of them could result in delays, increased costs, decreases in the amount of expected revenues or synergies, and diversion of management’s time and energy, which could materially affect our financial position, results of operations, and cash flows.

We have incurred substantial expenses in connection with the completion of the merger with Milacron and we expect to incur further expenses in order to integrate a large number of processes, policies, procedures, operations, technologies, and systems of Milacron in connection with the merger.

3. We have a significant amount of debt, which could adversely affect the Company and limit our ability to respond to changes in our business or make future desirable acquisitions.

As of June 30, 2020, our outstanding debt was $1,711.1. The amount of debt could increase if additional levels of liquidity are needed, including as a result of conditions created by COVID-19. This level of debt (and additional debt we may incur after that date) has important consequences to our businesses. For example:

•We may be more vulnerable to general adverse economic and industry conditions, because we have lower borrowing capacity.

•We may be required to dedicate a larger portion of our cash flow from operations to payments on our indebtedness, thereby reducing the availability of our cash flow for other purposes, including business development efforts and acquisitions, working capital requirements, and capital expenditures.

Table of Contents

•We will continue to be exposed to the risk of increased interest rates, because a portion of our borrowings is at variable rates of interest.

•We may be more limited in our flexibility in planning for, or reacting to, changes in our businesses and the industries in which they operate, thereby placing us at a competitive disadvantage compared to competitors that have less indebtedness.

•We may be more vulnerable to credit rating downgrades which could have an impact on our ability to secure future financing at attractive interest rates.

During the three months ended June 30, 2020, primarily due to COVID-19 and its anticipated economic impact, our credit rating was downgraded by Moody’s, S&P Global, and Fitch, and we may be vulnerable to additional downgrades. This downgrade and/or additional downgrades could have an impact on our ability to secure future financing at attractive interest rates, to access the credit and capital markets, or to negotiate favorable covenants in any future amendments to our financial documents or new financings.

While we have publicly stated that we will seek to deleverage our business, there can be no assurances that we will successfully achieve our deleveraging targets within our anticipated timeline or at all, especially in light of the COVID-19 pandemic and its impact on our business and cash flows. In order to achieve our targeted leverage ratios, we currently plan to curtail material acquisitions and share repurchases, and as a result, may forego opportunities that might otherwise be beneficial to the Company. Additionally, at any time and from time to time, we may evaluate or pursue one or more strategic options, including potential sale transactions, for a portion of the assets acquired in the merger or other assets. There can be no assurances if or when the Company would enter into any such transaction or the terms thereof or whether any such transaction would result in the Company achieving its desired leverage targets. The failure to achieve such deleveraging targets could result in a negative impact to the Company’s credit ratings, impair its ability to raise future indebtedness, or otherwise adversely impact its operating or financial condition or performance.

4. If we are unable to comply with the financial and other covenants in our debt agreements, our business, financial condition, and liquidity could be materially adversely affected.

Our Credit Agreement, the L/G Facility Agreement, and the Shelf Agreement contain financial and other restrictive covenants. These covenants could adversely affect us by limiting our financial and operating flexibility as well as our ability to plan for and react to market conditions, including as a result of the COVID-19 pandemic and its effect on our business, and to meet our capital needs. Our failure to comply with these covenants, including as a result of the COVID-19 pandemic and its effect on our business, could result in events of default which, if not cured or waived, could result in us being required to repay indebtedness before its due date, and we may not have the financial resources or be able to arrange alternative financing to do so. Any event that requires us to repay any of our debt before it is due could require us to borrow additional amounts at unfavorable borrowing terms, cause a significant reduction in our liquidity, and impair our ability to pay amounts due on our indebtedness. Moreover, if we are required to repay any of our debt before it becomes due, we may be unable to borrow additional amounts or otherwise obtain the cash necessary to repay that debt when due, which could materially adversely affect our business, financial condition, and liquidity. Furthermore, the current market volatility and economic downturn as a result of the COVID-19 pandemic may adversely impact the rates at which we are able to borrow and our ability to borrow under the Revolver or any other credit facility in the future, or pursuant to other available sources. In addition, in light of the impacts to our ability to generate cash from operations during the COVID-19 pandemic, our results may be further negatively impacted by our payment obligations (including interest) with respect to our outstanding borrowings under the Revolver and our other credit agreements.

5. Goodwill and other identifiable intangible assets, which are subject to periodic impairment evaluations, represent a significant portion of our total assets. An impairment charge on these assets could have a material adverse impact on our financial condition and results of operations.

We acquired intangible assets with the acquisitions of Milacron, Coperion, K-Tron (including TerraSource Global), Rotex, Abel, Red Valve, and BM&M, portions of which were identified as either goodwill or indefinite-lived assets. We periodically assess these assets to determine if they are impaired. Significant negative industry or economic trends, disruptions to our business, inability to effectively integrate acquired businesses, unexpected significant changes or planned changes in use of the assets, divestitures, and market capitalization declines may impair these assets, and any of these factors may be increasingly present during the COVID-19 pandemic.

As required by applicable accounting standards, we review goodwill and other identifiable intangible assets for impairment either annually or whenever changes in circumstances indicate that the carrying value may not be recoverable. The risk of impairment to goodwill is higher during the early years following an acquisition. This is because the fair values of these assets

Table of Contents

align very closely with what we paid to acquire the reporting units to which these assets are assigned. As a result, the difference between the carrying value of the reporting unit and its fair value (typically referred to as “headroom”) is smaller at the time of acquisition. Until this headroom grows over time, due to business growth or lower carrying value of the reporting unit, a relatively small decrease in reporting unit fair value can trigger impairment charges. When impairment charges are triggered, they tend to be material due to the size of the assets involved. The recency and relative size of the Milacron acquisition have elevated and could further elevate the risk of such impairment charges, including material impairment charges. Future acquisitions could present the same risks.

Any charges relating to such impairments could adversely affect our results of operations in the periods recognized.

6. We rely upon our employees, agents, and business partners to comply with laws in many different countries and jurisdictions. We establish policies and provide training to assist them in understanding our policies and the regulations most applicable to our business; however, our reputation, ability to do business, and financial results may be impaired by improper conduct by these parties.

We cannot provide assurance that our internal controls and compliance systems will always protect us from acts committed by our employees, agents, or business partners that would violate U.S. and/or non-U.S. laws, including laws governing payments to government officials, bribery, fraud, anti-kickback, false claims, competition, export and import compliance, including the U.S. Commerce Department’s Export Administration Regulations, trade sanctions promulgated by the Office of Foreign Asset Control (“OFAC”), anti-money laundering, and data privacy. In particular, the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act, and similar anti-bribery laws in other jurisdictions generally prohibit companies and their intermediaries, including us, from making improper payments to government officials or other parties for the purpose of obtaining or retaining business, and we operate in many parts of the world that have experienced corruption to some degree. Consequently, we are subject to the jurisdiction of various governments and regulatory agencies outside of the U.S., which may bring our personnel into contact with foreign officials responsible for issuing or renewing permits, licenses or approvals or for enforcing other governmental regulations. In addition, some of the international locations in which we operate lack a developed legal system and have elevated levels of corruption. Our global operations expose us to the risk of violating, or being accused of violating, the foregoing or other anti-corruption laws. Any such improper actions could subject us to civil or criminal investigations in the U.S. and in other jurisdictions; could lead to substantial civil and criminal, monetary, and non-monetary penalties, and related shareholder lawsuits; could cause us to incur significant legal fees; and could damage our reputation.

7. We are exposed to a number of different tax uncertainties, which could have a material adverse effect on our results of operations.

We are required to pay taxes in multiple jurisdictions. We determine the tax liability we are required to pay based on our interpretation of applicable tax laws and regulations in the jurisdictions in which we operate. We may be subject to unfavorable changes, including retroactive changes, in the tax laws and regulations to which we are subject.

We are subject to tax audits by governmental authorities in the United States and numerous non-U.S. jurisdictions, which are inherently uncertain. Negative or unexpected results from one or more such tax audits could adversely affect our results of operations. Tax controls and changes in tax laws or regulations or the interpretation given to them may expose us to negative tax consequences, including interest payments and potential penalties, which could have a material adverse effect on our results of operations.

8. We continually assess the strategic fit of our existing businesses and may divest or otherwise dispose of businesses that are deemed not to fit with our strategic plan or are not achieving the desired return on investment, and we cannot be certain that our business, operating results and financial condition will not be materially and adversely affected.

A successful divestiture depends on various factors, including reaching an agreement with potential buyers on terms we deem attractive, our ability to effectively transfer liabilities, contracts, facilities, and employees to any purchaser, identify and separate the intellectual property to be divested from the intellectual property that we wish to retain, reduce fixed costs previously associated with the divested assets or business, and collect the proceeds from any divestitures. These efforts require varying levels of management resources, which may divert our attention from other business operations. If we do not realize the expected benefits of any divestiture transaction, our consolidated financial position, results of operations, and cash flows could be negatively impacted. In addition, divestitures of businesses involve a number of risks, including significant costs and expenses, the loss of customer relationships, and a decrease in revenues and earnings associated with the divested business. Furthermore, divestitures potentially involve significant post-closing separation activities, which could involve the expenditure of material financial resources and significant employee resources. Any divestiture may result in a dilutive impact to our future earnings if we are unable to offset the dilutive impact from the loss of revenue associated with the divestiture, as well as

Table of Contents

significant write-offs, including those related to goodwill and other intangible assets, which could have a material adverse effect on our results of operations and financial condition.

9. We operate in cyclical industries.

As an industrial capital goods supplier, we serve industries that are cyclical and sensitive to changes in general economic conditions, such as packaging, automotive, construction, consumer goods, electronics, chemicals, and plastics industries. The performance of many of our business is directly related to the production levels of our customers. In particular, prices for plastic resins used to make plastic products and parts tend to fluctuate to a greater degree than our customers can adjust for in the pricing of their products. When resin prices increase, certain of our customers’ profit margins decrease, which may result in lower demand for our products. Therefore, our business is affected by fluctuations in the price of resin, which could have an adverse effect on our business and ability to generate operating cash flows.

During periods of economic expansion, when capital spending normally increases, the Process Equipment Group and Milacron businesses generally benefit from greater demand for their products. During periods of economic contraction, such as during the ongoing COVID-19 pandemic, when capital spending normally decreases, the Process Equipment Group and Milacron businesses generally are adversely affected by declining demand for new equipment orders, and may be subject to increases in uncollectible receivables from customers who become insolvent. There can be no assurance that economic expansion or increased demand will be sustainable, and our financial condition, results of operations, and cash flows could be materially adversely affected.

10. We derive significant revenues from the plastics industry. Decrease in demand for base resin or engineering plastics or equipment used in the production of these products, or changes in technological advances, or changes in laws or regulations could have a material adverse effect on our business, financial condition, and results of operations.

Approximately 90% of Milacron sales are realized from the manufacture, distribution, and service of highly engineered and customized systems within the plastic technology and processing market. The Process Equipment Group sells equipment, including highly engineered extruders, feeders, and conveying systems, to the plastics industry for the production of base resins, durable engineering grade plastics, and other compounded plastics (including bioplastics and recycled plastic product). Sales volume is dependent upon the need for equipment used to produce these products, which may be significantly influenced by the demand for plastics, the capital investment needs of companies in the plastics industry, changes in technological advances, or changes in laws or regulations. Unfavorable developments in the plastics industry could have a material adverse effect on our business, financial condition, and results of operations.

11. We operate in highly competitive industries, many of which are currently subject to intense price competition, and if we are unable to compete successfully, it could have a material adverse effect on our business, financial condition, and results of operations.

Many of the industries in which we operate are highly competitive. Our products may not compete successfully with those of our competitors. The markets for plastic processing equipment and related products, material handling equipment, complete equipment systems, mold components, burial caskets, and minerals and mining equipment, are highly competitive and include a number of North American, European, and Asian competitors. Principal competitive factors in the plastic processing industry, material handling equipment, and complete equipment systems include price, lead time, product features, technology, total cost of ownership, performance, reliability, quality, delivery, and customer service. Principal competitive factors in the mold components industry include technology, price, quality, performance, and delivery. Principal competitive factors in the burial caskets industry include product, price, delivery, and customer service. Principal competitive factors in the minerals and mining industry include product features, performance, price, delivery, and customer service.

Our competitors may be positioned to offer more favorable pricing to customers, resulting in reduced volume and profitability. In certain cases, we have lost business to competitors who offered prices lower than ours. Competition may also limit our ability to pass on the effects of increases in our cost structure. In addition, some of our competitors may have greater financial resources and less debt than we do, which may place us at a competitive disadvantage in the future. These competitors may be better able to withstand and respond to changes in conditions within our industry.

Competition in any of these areas may reduce our sales and adversely affect our earnings or cash flow by resulting in decreased sales volumes, reduced prices, and increased costs of manufacturing, distributing and selling our products.

12. Uncertainty in the United States political environment and in trade policy could negatively impact our business.

The political environment in the United States has created significant uncertainty with respect to, and has resulted in and could

Table of Contents

result in additional changes in, legislation, regulation, international relations, and government policy. While it is not possible to

predict whether and when any such additional changes will occur, changes at the local, state or federal level could significantly

impact our business and the industries in which we compete. Specific legislative and regulatory developments and proposals that could have a material impact on us involve matters including (but not limited to) changes to existing trade agreements or entry into new trade agreements, sanctions policies, import and export regulations, tariffs, taxes and customs duties, public company reporting requirements, environmental regulation, and antitrust enforcement. In addition, certain countries that are central to our businesses have imposed and/or been subject to imposition or have threatened imposition of retaliatory tariffs in response to tariffs imposed by the U.S. upon various raw materials and finished goods, including steel and others that are important to our businesses. To the extent changes in the political or regulatory environment have a negative impact on the Company or the markets in which we operate, it may materially and adversely impact our business, results of operations and financial condition in the periods to come.

The U.S. government has at times indicated a willingness to significantly change, and has in some cases significantly changed,

trade policies and/or agreements. This exposes us to risks of disruption and cost increases in our established patterns for sourcing our raw materials, and creates increased uncertainties in planning our sourcing strategies and forecasting our margins. Changes in U.S. tariffs, quotas, trade relationships or agreements, or tax law could reduce the supply of goods available to us or increase our cost of goods. Although such changes would in many cases have implications across the entire industry, we may fail to effectively adapt to and manage the adjustments in strategy that would be necessary in response to those changes. In addition to the general uncertainty and overall risk from potential changes in U.S. laws and policies, as we make business decisions in the face of uncertainty, we may incorrectly anticipate the outcomes, miss out on business opportunities or fail to effectively adapt our business strategies and manage the adjustments that are necessary in response to those changes. These risks could materially and adversely impact our business, results of operations and financial condition in the periods to come.

Further, the level of impact of COVID-19 and the reactions of governmental authorities and others thereto may have significant adverse effects on international trade policy and the impact of any changes in international trade policy on the economy or on the businesses of the Company and those of its customers and its suppliers remains uncertain.

Item 6. EXHIBITS

The exhibits filed with this report are listed below. In reviewing any agreements included as exhibits to this report, please remember that they are included to provide you with information regarding their terms and are not intended to provide any other factual or disclosure information about us or the other parties to the agreements. The agreements may contain representations and warranties by the parties to the agreements, including us. Except where explicitly stated otherwise, these representations and warranties have been made solely for the benefit of the other parties to the applicable agreement and:

•should not necessarily be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate;

•may have been qualified by disclosures that were made to the other party in connection with the negotiation of the applicable agreement, which disclosures are not necessarily reflected in the agreement;

•may apply standards of materiality in a way that is different from what may be viewed as material to you or other investors; and

•were made only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement and are subject to more recent developments.

Accordingly, these representations and warranties may not describe the actual state of affairs as of the date they were made or at any other time.

Table of Contents

Exhibit 3.1

Restated and Amended Articles of Incorporation of Hillenbrand, Inc., effective February 13, 2020 (Incorporated by reference to Exhibit 3.1 to Current Report on Form 8-K filed February 14, 2020)

Exhibit 3.2

Amended and Restated Code of By-laws of Hillenbrand, Inc. (Incorporated by reference to Exhibit 3.2 to Current Report on Form 8-K filed February 14, 2020)

Exhibit 4.2

Supplemental Indenture No. 4, dated as of June 16, 2020, by and among the Company, the subsidiary guarantors party thereto and the Trustee (Incorporated by reference to Exhibit 4.2 to Current Report on Form 8-K filed June 16, 2020)

Exhibit 10.1

Amendment No. 4 to Third Amended and Restated Credit Agreement, dated as of May 19, 2020, among Hillenbrand, Inc., as a borrower, the subsidiary borrowers party thereto, the lenders party thereto, and JPMorgan Chase Bank, N.A., as administrative agent (Incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed May 20, 2020)

Exhibit 10.2

Amendment No. 7 to Private Shelf Agreement, dated as of May 19, 2020, among Hillenbrand, Inc., PGIM, Inc. (f/k/a Prudential Investment Management, Inc.), the subsidiary guarantors party thereto, and the additional parties thereto (Incorporated by reference to Exhibit 10.2 to Current Report on Form 8-K filed May 20, 2020)

Exhibit 10.3

Third Amendment and Restatement Agreement, dated as of May 19, 2020, among Hillenbrand, Inc., certain of its subsidiaries party thereto, the lenders party thereto, and Commerzbank Finance & Covered Bond S.A., acting as agent (Incorporated by reference to Exhibit 10.3 to Current Report on Form 8-K filed May 20, 2020)

Exhibit 22*

List of Guarantor Subsidiaries of Hillenbrand, Inc.

Exhibit 31.1*

Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Exhibit 31.2*

Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Exhibit 32.1*

Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Exhibit 32.2*

Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

The following documents are being filed pursuant to Inline XBRL:

Exhibit 101.INS

Instance document

Exhibit 101.SCH

Schema document

Exhibit 101.CAL

Calculation linkbase document

Exhibit 101.LAB

Labels linkbase document

Exhibit 101.PRE

Presentation linkbase document

Exhibit 101.DEF

Definition linkbase document

Exhibit 104

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

* Filed herewith.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	HILLENBRAND, INC.

Date: August 5, 2020	BY:	/s/ Kristina A. Cerniglia
		Kristina A. Cerniglia
		Senior Vice President and Chief Financial Officer

Date: August 5, 2020		/s/ Andrew S. Kitzmiller
		Andrew S. Kitzmiller
		Vice President, Controller, and Chief Accounting Officer